trigeminal neuralgia: Trigeminal neuralgia is a nerve disorder that causes a stabbing or electric-shock-like pain in parts of the face. The pain lasts a few seconds to a few minutes, and usually on only one side of the face. It can also cause muscle spasms in the face the same time as the pain. The pain may result from a blood vessel pressing against the trigeminal nerve (the nerve that carries pain, feeling, and other sensations from the brain to the skin of theface), as a complication of multiple sclerosis, or due to compression of the nerve by a tumor or cyst. In some cases, the cause is unknown. Treatment options include medicines, surgery, and complementary approaches.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
2323 |
4. Check minimum number of eventsNone |
2323 |
5. Include endpointsNone |
2323 |
6. Filter based on genotype QC (FinnGen only) |
2323 |
Control definitions (FinnGen only)
- Control exclude
- G6_NERPLEX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G50
- Name in latin
- Neuralgia trigeminalis
Similar endpoints
↥List of similar endpoints to
Trigeminal neuralgia
based on the number of shared cases.
Similar with more cases:
- Nerve, nerve root and plexus disorders
- Neurological diseases
- Neurological diseases, wide definition
- Pain (limb, back, neck, head abdominally)
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15546 | 10605 | 4805 |
| Only index persons | 13493 | 9534 | 3959 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.30 | 0.13 |
| Only index persons | 0.29 | 0.35 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 56.64 | 56.10 | 57.82 |
| Only index persons | 54.85 | 54.41 | 55.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2323 | 1632 | 691 |
| Unadjusted period prevalence (%) | 0.48 | 0.56 | 0.30 |
| Median age at first event (years) | 54.34 | 52.49 | 58.71 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2058
- Matched controls
- 20578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
+∞
323.0
543
*
G50.0
ICD-10 Finland
Trigeminal neuralgia
4915.4
323.0
1855
35
N03AF01
ATC
carbamazepine; oral, rectal
75.8
323.0
1243
405
G50.1
ICD-10 Finland
Atypical facial pain
109.0
323.0
382
43
N03AX12
ATC
gabapentin; oral
8.3
308.6
800
1457
N03AF02
ATC
oxcarbazepine; oral
29.0
305.9
423
182
N03AX16
ATC
pregabalin; oral
5.6
248.5
928
2614
R51.81
ICD-10 Finland
Facial pain NOS
22.5
193.2
287
147
M03BX01
ATC
baclofen; systemic
29.5
174.8
239
91
G56.0
ICD-10 Finland
Carpal tunnel syndrome
16.8
169.7
280
191
N02AX02
ATC
tramadol; systemic, rectal
3.3
139.2
1127
5541
R51.80
ICD-10 Finland
Headache
4.3
123.8
537
1557
G50.9
ICD-10 Finland
Disorder of trigeminal nerve, unspecified
+∞
121.0
115
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.8
114.2
356
717
N92
ICPC
Trigeminal neuralgia
561.7
108.8
107
*
N03AX09
ATC
lamotrigine; oral
7.9
104.4
254
362
AAH30
NOMESCO Finland
Thermal destruction of cranial nerve
+∞
98.7
94
*
ACC51
NOMESCO Finland
Release of median nerve
85.1
94.1
105
13
AAH60
NOMESCO Finland
Microvascular decompression of cranial nerve
+∞
90.3
86
*
N06AA09
ATC
amitriptyline; systemic
4.4
90.0
368
978
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
74.1
87.1
99
14
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
841.2
83.1
81
*
N03AE01
ATC
clonazepam; systemic
5.8
75.8
230
438
3501A
ICD-9 Finland
Trigeminal nerve disorders, Trigeminal neuralgia
+∞
75.5
72
*
N06AX21
ATC
duloxetine; oral
3.9
74.7
348
1029
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.4
72.2
290
747
K07.60
ICD-10 Finland
Snapping jaw
5.5
71.7
226
449
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
3.8
67.7
324
975
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
4.5
66.4
257
636
N03
ICPC
Pain face
23.4
63.7
92
41
A02BC05
ATC
esomeprazole; systemic
2.2
60.5
948
5763
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
60.2
355
1249
35199
ICD-8 Finland
Trigeminal neuralgia
+∞
59.7
57
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.9
59.6
208
461
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
57.9
913
5529
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
57.6
831
4832
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
10.4
56.8
114
115
A02BC02
ATC
pantoprazole; systemic
2.1
56.6
1402
10266
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
55.8
1010
6459
R52.2
ICD-10 Finland
Other chronic pain
7.0
54.8
141
214
G51.0
ICD-10 Finland
Bell palsy
46.1
54.8
67
15
AA1AD
NOMESCO Finland
CT of head and brain
2.4
53.5
566
2812
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.9
53.5
381
1512
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
3.2
53.5
323
1148
H02AB06
ATC
prednisolone; systemic
2.1
53.2
1029
6714
M79.6
ICD-10 Finland
Pain in limb
2.1
52.9
804
4733
K08.80
ICD-10 Finland
Toothache NOS
3.6
52.6
260
795
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.8
51.9
183
409
N06AX16
ATC
venlafaxine; oral
2.9
51.4
366
1448
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
50.6
666
3658
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
12.1
50.2
93
80
G54.0
ICD-10 Finland
Brachial plexus disorders
24.1
49.1
70
30
M25.5
ICD-10 Finland
Pain in joint
2.2
48.9
657
3633
M03BX02
ATC
tizanidine; oral
2.0
48.8
1306
9552
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
6.2
48.6
136
231
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.0
48.1
308
1134
G44.2
ICD-10 Finland
Tension-type headache
2.8
48.0
357
1446
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
48.0
613
3306
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.7
47.9
127
201
M54.5
ICD-10 Finland
Low back pain
2.1
47.6
734
4299
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.9
47.5
331
1289
N02BE01
ATC
paracetamol; systemic, rectal
2.5
47.3
1793
15096
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.0
47.2
1170
8255
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
46.8
788
4778
R42
ICD-10 Finland
Dizziness and giddiness
2.3
46.3
522
2648
N01
ICPC
Headache
3.2
46.0
273
951
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
46.0
1444
11098
SAA03
NOMESCO Finland
Extended examination of mouth
2.0
45.6
837
5240
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.4
45.5
240
768
M54.4
ICD-10 Finland
Lumbago with sciatica
2.6
45.1
392
1735
TAB00
NOMESCO Finland
Lumbar puncture
5.1
45.0
149
310
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
44.7
840
5293
G50
ICD-10 Finland
Disorders of trigeminal nerve
447.0
44.4
44
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
44.1
1026
6994
M03BC01
ATC
orphenadrine (citrate); systemic
2.2
43.2
545
2899
R03AC02
ATC
salbutamol; inhalant
1.9
42.2
1108
7845
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.6
42.1
153
352
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
41.5
514
2706
M79.1
ICD-10 Finland
Myalgia
2.6
40.4
326
1376
M01AE02
ATC
naproxen; oral, rectal
1.9
40.4
1179
8601
G35
ICD-10 Finland
Multiple sclerosis
8.6
40.0
89
108
A02BC03
ATC
lansoprazole; oral
2.0
39.0
655
3899
R52.9
ICD-10 Finland
Pain, unspecified
3.1
38.1
227
791
R01AD09
ATC
mometasone; nasal
1.8
37.5
956
6593
P01AB01
ATC
metronidazole; oral, rectal
1.8
36.6
873
5866
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
36.2
467
2478
R20.2
ICD-10 Finland
Paraesthesia of skin
3.4
36.2
188
592
J01DB01
ATC
cefalexin; oral
2.0
36.1
1655
13851
G44.0
ICD-10 Finland
Cluster headache syndrome
12.6
36.1
65
53
J01AA02
ATC
doxycycline; systemic
2.0
35.9
1619
13443
M01AB05
ATC
diclofenac; systemic, rectal
1.8
35.8
1360
10631
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
35.5
497
2732
N03AX11
ATC
topiramate; oral
6.1
35.3
99
169
R06.0
ICD-10 Finland
Dyspnoea
2.0
35.1
529
2993
J01FA10
ATC
azithromycin; systemic
1.8
34.9
1187
8911
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
34.7
408
2071
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
34.7
608
3642
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
34.0
256
1033
F45.8
ICD-10 Finland
Other somatoform disorders
3.2
33.9
192
644
WX110
NOMESCO Finland
Local anesthesy
1.8
33.1
1373
10882
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.0
32.9
200
704
SBB10
NOMESCO Finland
Teeth copy
3.6
32.6
157
465
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.6
32.4
154
451
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
32.2
1018
7389
R51
ICD-10 Finland
Headache
3.5
32.0
157
472
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.4
31.8
120
286
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
31.8
874
6062
109
Kela drug reimbursment
Multiple sclerosis
9.0
31.7
68
78
G56.2
ICD-10 Finland
Lesion of ulnar nerve
15.8
31.3
51
33
L03
ICPC
Low back symptom/complaint
2.0
30.9
498
2871
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.2
30.8
174
581
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.6
30.7
145
423
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.8
30.7
219
854
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
30.5
593
3657
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.9
30.4
201
744
N06AA10
ATC
nortriptyline; systemic
5.6
30.2
90
166
J02AC01
ATC
fluconazole; systemic
1.7
30.2
885
6232
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
29.9
536
3209
G43.9
ICD-10 Finland
Migraine, unspecified
3.3
29.6
158
507
G44.8
ICD-10 Finland
Other specified headache syndromes
9.5
29.5
61
66
J01FF01
ATC
clindamycin; systemic
1.9
29.3
560
3427
M54.2
ICD-10 Finland
Cervicalgia
3.0
28.7
173
602
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
28.7
330
1648
J01MA02
ATC
ciprofloxacin; systemic
1.7
28.6
784
5382
A02BC01
ATC
omeprazole; systemic
1.8
28.5
586
3669
M01AH05
ATC
etoricoxib; oral
1.7
28.5
1157
8905
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
28.4
361
1882
H57.1
ICD-10 Finland
Ocular pain
4.4
28.1
105
248
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.0
28.1
117
306
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
27.9
819
5727
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
27.8
671
4416
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
6.1
27.8
77
130
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.4
27.7
246
1082
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
27.6
1028
7690
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
27.5
464
2704
N05BA01
ATC
diazepam; systemic, rectal
2.2
27.5
305
1496
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
27.5
167
586
A02BA02
ATC
ranitidine; systemic
2.0
27.5
421
2367
J01FA06
ATC
roxithromycin; oral
1.7
27.4
831
5859
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
27.0
347
1813
N86
ICPC
Multiple sclerosis
14.3
26.7
45
32
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
26.6
156
534
R53
ICD-10 Finland
Malaise and fatigue
1.9
26.3
443
2573
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.8
26.3
510
3114
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.5
26.2
229
997
N03AG01
ATC
valproic acid; systemic, rectal
3.0
26.2
159
555
H01
ICPC
Ear pain/earache
2.4
26.1
232
1020
A01
ICPC
Pain general/multiple sites
2.7
26.1
188
734
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.0
26.1
157
548
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
26.1
25
*
R52.1
ICD-10 Finland
Chronic intractable pain
11.7
25.9
48
42
N02AA05
ATC
oxycodone; systemic
2.2
25.5
302
1524
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
8.2
25.4
57
71
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
6.4
25.4
68
110
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.3
25.4
243
1110
S18
ICPC
Laceration/cut
1.7
25.2
792
5602
R03DC03
ATC
montelukast; oral
2.0
25.1
345
1849
Z01.2
ICD-10 Finland
Dental examination
1.7
24.9
811
5786
M79.7
ICD-10 Finland
Fibromyalgia
3.9
24.7
106
285
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
24.7
464
2792
WZA90
NOMESCO Finland
Other doctors statement
1.8
24.1
459
2775
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
23.9
347
1898
J05AB01
ATC
aciclovir; systemic
1.8
23.8
447
2687
SPAT1263
SPAT
Sampling
1.6
23.7
825
5967
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
7.5
23.7
56
76
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
23.7
828
6002
R06AE07
ATC
cetirizine; oral
1.6
23.5
868
6375
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
6.7
23.4
60
92
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
23.3
399
2318
H92.0
ICD-10 Finland
Otalgia
3.2
23.3
126
408
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.4
23.2
71
136
N06AX11
ATC
mirtazapine; oral
1.7
23.1
643
4365
R01AD08
ATC
fluticasone; nasal
1.7
23.1
577
3792
C08DA01
ATC
verapamil; systemic
3.3
23.1
118
367
SPAT1153
SPAT
Removal of sutures
1.7
23.1
600
3993
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
23.1
519
3307
UJF32
NOMESCO Finland
Coloscopy
1.8
23.0
511
3241
H02AB04
ATC
methylprednisolone; systemic
2.0
22.9
308
1631
M01AG02
ATC
tolfenamic acid; oral, rectal
2.0
22.8
350
1951
R07.3
ICD-10 Finland
Other chest pain
2.4
22.8
211
946
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
22.8
218
993
L01
ICPC
Neck symptom/complaint
2.1
22.8
283
1452
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
22.7
199
866
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
16.6
22.7
36
22
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
22.6
184
770
UKC02
NOMESCO Finland
Cystoscopy
2.1
22.6
298
1567
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.9
22.6
140
498
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
21.9
642
4405
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.4
21.9
108
327
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
13.9
21.8
37
27
WX290
NOMESCO Finland
Other blockade of nerve
1.6
21.8
820
6018
N06AB04
ATC
citalopram; systemic
1.8
21.5
447
2770
J01DA01
ATC
[U] cefalexin; systemic
1.6
21.5
1237
10068
N02AC04
ATC
dextropropoxyphene; oral
3.5
21.4
102
301
C07AB07
ATC
bisoprolol; oral
1.6
21.3
870
6503
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
21.3
515
3339
J01FA09
ATC
clarithromycin; systemic
1.7
21.3
632
4347
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.2
21.1
230
1112
R03BA05
ATC
fluticasone; inhalant
1.9
21.0
369
2159
R05
ICPC
Cough
1.8
21.0
430
2648
N03AB02
ATC
phenytoin; systemic
7.6
20.9
49
66
AAH40
NOMESCO Finland
Glycerol injection into cranial nerve
+∞
20.9
20
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
20.7
1082
8570
M48.0
ICD-10 Finland
Spinal stenosis
2.2
20.5
220
1056
A01AB09
ATC
miconazole; local oral
2.3
20.5
208
974
J05AB11
ATC
valaciclovir; oral
2.0
20.3
275
1456
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
20.1
579
3938
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
20.0
148
587
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
19.9
274
1460
L03AB07
ATC
interferon beta-1a; parenteral
10.7
19.9
38
36
2181
FHL
Root fracture, decompression or coagulation
+∞
19.8
19
*
K02.1
ICD-10 Finland
Caries of dentine
1.5
19.8
1049
8297
J01EA01
ATC
trimethoprim; systemic
1.7
19.6
539
3612
H53.2
ICD-10 Finland
Diplopia
4.1
19.5
78
198
C07AA05
ATC
propranolol; systemic
1.8
19.4
386
2347
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
19.3
154
637
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.8
19.2
131
496
SGA01
NOMESCO Finland
Tooth opening as first aid
1.9
19.1
305
1717
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
19.1
170
743
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
19.0
566
3870
L12
ICPC
Hand/finger symptom/complaint
2.0
18.9
265
1424
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.2
18.8
192
900
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
18.8
238
1227
R02
ICPC
Shortness of breath/dyspnoea
2.1
18.7
237
1223
A06AD11
ATC
lactulose; oral
1.9
18.6
287
1596
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
9.4
18.6
38
41
M54.1
ICD-10 Finland
Radiculopathy
3.5
18.6
89
264
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
18.6
161
695
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
18.4
575
3979
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.5
18.4
86
250
R13
ICD-10 Finland
Dysphagia
2.6
18.3
141
571
M01AH02
ATC
rofecoxib; oral
2.0
18.2
265
1442
R03BA01
ATC
beclometasone; inhalant
1.9
18.2
294
1665
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.1
18.1
103
346
N05CF01
ATC
zopiclone; oral
1.6
18.0
636
4534
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
17.9
343
2056
SPAT1260
SPAT
Consultation of another employee
1.8
17.8
342
2053
M02AA07
ATC
piroxicam; topical
1.6
17.6
702
5148
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.4
17.6
88
270
N05AH04
ATC
quetiapine; oral
1.9
17.6
302
1744
L08
ICPC
Shoulder symptom/complaint
1.8
17.6
358
2185
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
6.8
17.6
44
66
N05BA04
ATC
oxazepam; oral
1.6
17.5
487
3260
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.2
17.3
91
291
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
17.1
318
1882
M01AH01
ATC
celecoxib; oral (coxibs)
1.8
17.1
354
2173
R01AD01
ATC
beclometasone; nasal
1.8
17.1
306
1790
J01MA12
ATC
levofloxacin; systemic
1.8
17.1
352
2156
L11
ICPC
Wrist symptom/complaint
2.4
17.1
149
646
M01AC06
ATC
meloxicam; systemic, rectal
1.5
17.0
695
5118
R01AD12
ATC
fluticasone furoate; nasal
1.6
16.9
561
3926
KMAK
NOMESCO Finland
NA
1.5
16.9
984
7831
WX002
NOMESCO Finland
Sedation and analgesia
1.7
16.9
383
2415
G47.3
ICD-10 Finland
Sleep apnoea
1.8
16.8
351
2159
SPAT1301
SPAT
No procedures
1.6
16.8
600
4277
J01CA04
ATC
amoxicillin; systemic
1.6
16.8
1553
13666
A07AA02
ATC
nystatin; oral
2.4
16.7
144
620
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.2
16.7
88
281
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
16.7
328
1979
SPAT1254
SPAT
Administration of medicine
1.9
16.7
273
1549
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.6
16.6
121
475
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
16.6
121
476
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
2.0
16.5
219
1147
G56.4
ICD-10 Finland
Causalgia
171.3
16.5
17
*
H03AA01
ATC
levothyroxine sodium; systemic
1.6
16.4
491
3341
XKD00
NOMESCO Finland
Uroflowmetry
1.9
16.4
240
1308
Z3226
NOMESCO Finland
Physiotherapist
1.7
16.3
356
2218
L13
ICPC
Hip symptom/complaint
1.8
16.3
306
1820
L28
ICPC
Limited function/disability (L)
1.8
16.3
291
1703
R74
ICPC
Upper respiratory infection acute
1.6
16.2
508
3498
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.9
16.2
242
1329
ZXA00
NOMESCO Finland
Right side
1.6
16.1
485
3304
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
16.1
272
1561
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.4
16.0
134
570
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.5
16.0
75
220
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.6
15.9
73
210
R06AX27
ATC
desloratadine; oral
1.6
15.9
513
3553
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
15.9
372
2364
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
15.9
1183
9862
R75
ICPC
Sinusitis acute/chronic
2.8
15.8
101
367
N06AB10
ATC
escitalopram; oral
1.7
15.8
368
2335
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.2
15.8
162
763
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.5
15.7
46
85
R11
ICD-10 Finland
Nausea and vomiting
2.2
15.7
166
792
N30.0
ICD-10 Finland
Acute cystitis
1.8
15.7
279
1630
N02CC03
ATC
zolmitriptan; nasal, oral
2.4
15.7
134
575
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
15.6
333
2059
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
15.5
728
5502
M54.3
ICD-10 Finland
Sciatica
2.5
15.5
122
502
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
5.0
15.5
49
99
EBA00
NOMESCO Finland
Extraction of tooth
1.5
15.5
573
4105
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
15.5
201
1045
A03FA02
ATC
cisapride; oral, rectal
2.2
15.4
166
798
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
15.4
1287
10947
L17
ICPC
Foot/toe symptom/complaint
1.6
15.4
443
2982
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
15.3
212
1127
M54.6
ICD-10 Finland
Pain in thoracic spine
2.4
15.3
138
609
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
15.3
198
1027
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
15.3
144
651
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.7
15.3
383
2481
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
15.2
812
6298
R96
ICPC
Asthma
2.1
15.2
176
873
S06.0
ICD-10 Finland
Concussion
2.0
15.2
189
968
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
15.1
139
618
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.7
15.1
66
183
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
15.1
265
1537
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
15.0
159
759
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
6.2
15.0
40
66
N06AB03
ATC
fluoxetine; oral
1.9
15.0
252
1442
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
14.9
85
287
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
14.9
187
961
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.1
14.9
82
272
ACC53
NOMESCO Finland
Release of ulnar nerve
57.1
14.8
17
*
M50.3
ICD-10 Finland
Other cervical disc degeneration
3.9
14.8
61
161
R03AK08
ATC
formoterol and beclometasone; inhalant
3.0
14.7
86
296
J01DA06
ATC
[U] cefuroxime; systemic
1.8
14.7
281
1678
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
14.7
383
2502
D07AC01
ATC
betamethasone; topical
1.5
14.7
627
4631
SPAT1216
SPAT
Assessment of functional ability
1.8
14.6
283
1696
G51.9
ICD-10 Finland
Disorder of facial nerve, unspecified
+∞
14.6
14
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
14.6
765
5899
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.1
14.6
167
825
Z71.8
ICD-10 Finland
Other specified counselling
1.6
14.5
426
2876
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
14.5
680
5117
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
14.5
1752
16032
M01AX01
ATC
nabumetone; oral
2.7
14.5
99
377
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.2
14.4
152
723
SPAT1310
SPAT
Counselling related to known health issue
1.5
14.4
572
4155
K10.3
ICD-10 Finland
Alveolitis of jaws
2.8
14.3
96
359
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
14.3
274
1635
L03AX13
ATC
glatiramer acetate; parenteral
9.2
14.2
29
32
R01AD05
ATC
budesonide; nasal
2.1
14.2
160
786
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
14.1
408
2740
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
14.1
140
647
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.5
14.1
110
452
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
14.0
206
1122
K30
ICD-10 Finland
Functional dyspepsia
1.9
14.0
206
1122
A03CA02
ATC
clidinium and psycholeptics; oral
2.3
14.0
134
609
XQ800
NOMESCO Finland
Prick test
2.2
13.9
148
707
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
13.9
350
2268
Z3231
NOMESCO Finland
Registered nurse
1.5
13.8
491
3468
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
53.7
13.8
16
*
K04.00
ICD-10 Finland
Hyperemia of pulp
2.7
13.8
93
349
J31.0
ICD-10 Finland
Chronic rhinitis
2.1
13.8
152
736
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
13.8
507
3610
A04
ICPC
Weakness/tiredness general
1.8
13.7
241
1397
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.1
13.6
53
133
SXC05
NOMESCO Finland
Other oral or dental procedure
2.4
13.6
113
479
R05
ICD-10 Finland
Cough
1.6
13.6
362
2377
SPAT1312
SPAT
General health counselling
1.5
13.5
566
4143
XCK00
NOMESCO Finland
Perimetry
2.2
13.5
139
656
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.9
13.4
211
1179
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.0
13.4
180
948
N04BC05
ATC
pramipexole; oral
2.2
13.4
136
638
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
4.1
13.4
51
126
G43.3
ICD-10 Finland
Complicated migraine
4.8
13.3
44
94
H02.4
ICD-10 Finland
Ptosis of eyelid
3.4
13.3
63
187
N02CC04
ATC
rizatriptan; oral
2.3
13.3
127
576
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
8.6
13.2
28
33
M70.6
ICD-10 Finland
Trochanteric bursitis
1.8
13.2
241
1415
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.8
13.2
56
152
H46
ICD-10 Finland
Optic neuritis
6.4
13.2
34
54
UDC00
NOMESCO Finland
Ear microscopy
2.2
13.2
141
674
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.6
13.1
95
375
M01AB55
ATC
diclofenac, combinations; oral
2.2
13.0
138
659
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
13.0
196
1077
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
13.0
623
4689
N03A
ATC
ANTIEPILEPTICS
28.5
13.0
17
6
R50.9
ICD-10 Finland
Fever, unspecified
1.8
12.9
247
1472
R03BA02
ATC
budesonide; inhalant
1.6
12.9
327
2115
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
12.8
79
282
K59.0
ICD-10 Finland
Constipation
2.4
12.8
108
463
SPAT1240
SPAT
Therapeutic discussion
1.9
12.7
188
1025
L15
ICPC
Knee symptom/complaint
1.6
12.7
363
2422
K04.08
ICD-10 Finland
Other specified pulpit
2.3
12.7
123
562
Z2445
NOMESCO Finland
Psychologist
2.8
12.7
80
291
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.5
12.7
467
3318
L09
ICPC
Arm symptom/complaint
2.7
12.6
86
326
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
2.4
12.6
110
480
J01CA08
ATC
pivmecillinam; oral
1.4
12.6
830
6637
J01MA14
ATC
moxifloxacin; systemic
2.0
12.6
161
831
K11.2
ICD-10 Finland
Sialoadenitis
3.0
12.6
70
235
UDM02
NOMESCO Finland
Sinoscopy
3.6
12.6
55
154
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.5
12.5
36
66
N05BA12
ATC
alprazolam; oral
1.9
12.5
196
1092
R09
ICPC
Sinus symptom/complaint
2.1
12.5
152
767
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
12.5
338
2222
35399
ICD-8 Finland
Sciatica
+∞
12.5
12
*
G52.1
ICD-10 Finland
Disorders of glossopharyngeal nerve
+∞
12.5
12
*
M54
ICD-10 Finland
Dorsalgia
1.9
12.5
203
1148
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
20.2
12.5
18
9
G51.8
ICD-10 Finland
Other disorders of facial nerve
130.8
12.4
13
*
DFF00
NOMESCO Finland
Pure tone audiometry
2.0
12.4
170
901
-1
NOMESCO Finland
NA
1.5
12.4
592
4445
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
12.3
183
1001
M89.0
ICD-10 Finland
Algoneurodystrophy
8.0
12.3
27
34
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
11.7
12.3
22
19
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.8
12.3
212
1223
R4120
NOMESCO Finland
Occupational therapy
2.3
12.2
115
520
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
37.8
12.2
15
*
Z00.0
ICD-10 Finland
General medical examination
1.6
12.2
317
2064
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
12.2
94
383
E0000UV
ATC
NA
1.4
12.2
716
5594
L02
ICPC
Back symptom/complaint
1.9
12.1
174
940
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.1
12.1
67
224
H02AB07
ATC
prednisone; oral
1.7
12.1
270
1682
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
12.1
322
2108
G57.6
ICD-10 Finland
Lesion of plantar nerve
5.6
12.1
34
61
XA402
NOMESCO Finland
ENMG
3.9
12.1
48
124
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
12.0
220
1289
R06.2
ICD-10 Finland
Wheezing
2.6
12.0
84
326
M01AX17
ATC
nimesulide; oral
1.5
12.0
438
3099
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
12.0
238
1433
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.4
11.9
721
5659
K07.61
ICD-10 Finland
Cracking jaw joint
3.8
11.9
49
131
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.1
11.8
64
211
N05CF02
ATC
zolpidem; oral
1.6
11.8
332
2205
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
11.8
366
2490
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.2
11.7
117
544
K07.6
ICD-10 Finland
Temporomandibular joint disorders
6.7
11.7
29
44
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.9
11.7
182
1013
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.0
11.7
152
790
B02.9
ICD-10 Finland
Zoster without complication
2.3
11.7
106
472
L86
ICPC
Back syndrome with radiating pain
2.4
11.7
97
412
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.3
11.6
108
484
R55
ICD-10 Finland
Syncope and collapse
1.8
11.6
192
1089
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
11.6
298
1933
N02CC06
ATC
eletriptan; oral
2.6
11.6
82
320
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
11.6
81
314
XKC03
NOMESCO Finland
Water cystometry
2.9
11.6
69
243
K04.0
ICD-10 Finland
Pulpitis
1.9
11.6
169
918
N07CA01
ATC
betahistine; oral
2.0
11.5
145
747
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
4.8
11.5
37
78
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
11.5
157
835
SPAT1058
SPAT
PEF monitoring instruction
2.0
11.5
149
777
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
11.5
180
1006
N02CC05
ATC
almotriptan; oral
2.5
11.4
90
372
J46
ICD-10 Finland
Status asthmaticus
3.2
11.4
60
194
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
11.4
417
2945
L16
ICPC
Ankle symptom/complaint
1.9
11.4
168
917
A28
ICPC
Limited function/disability NOS
1.7
11.4
257
1608
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
6.1
11.3
30
50
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.7
11.3
37
79
C05AA08
ATC
fluocortolone; rectal, topical
1.7
11.3
266
1683
N20.1
ICD-10 Finland
Calculus of ureter
2.9
11.3
66
229
K04.09
ICD-10 Finland
Pulpit UNS
2.5
11.3
85
342
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.8
11.2
208
1224
N17
ICPC
Vertigo/dizziness
1.8
11.2
198
1150
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
11.2
228
1384
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
17.1
11.2
17
10
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.9
11.1
65
226
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.2
11.1
112
522
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
11.1
313
2076
M01AH03
ATC
valdecoxib; oral
2.1
11.1
120
580
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
11.1
446
3217
A01AB04
ATC
amphotericin B; local oral
2.3
11.1
105
478
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.1
11.0
124
610
J34.2
ICD-10 Finland
Deviated nasal septum
2.4
11.0
90
380
R00.2
ICD-10 Finland
Palpitations
2.1
11.0
132
665
ZXA10
NOMESCO Finland
Bilateral
1.6
11.0
336
2275
N06AA12
ATC
doxepin; systemic
2.3
10.9
104
475
G04BD07
ATC
tolterodine; oral
2.3
10.9
104
475
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
10.9
181
1031
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.8
10.9
45
121
N29
ICPC
Neurological sympt/complt other
3.7
10.8
45
122
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
10.8
92
398
R03BA08
ATC
ciclesonide; inhalant
1.9
10.8
159
868
M35.7
ICD-10 Finland
Hypermobility syndrome
4.3
10.8
39
93
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.1
10.7
58
192
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
2.1
10.7
117
567
R21
ICPC
Throat symptom/complaint
1.6
10.7
326
2207
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
10.7
91
393
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
10.6
107
501
P03
ICPC
Feeling depressed
1.9
10.6
146
779
A02BA04
ATC
nizatidine; systemic
1.9
10.6
150
809
L03AB08
ATC
interferon beta-1b; parenteral
11.3
10.5
19
17
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
10.5
127
643
R07.0
ICD-10 Finland
Pain in throat
2.2
10.5
110
523
P01
ICPC
Feeling anxious/nervous/tense
1.9
10.5
160
883
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
10.4
229
1420
AC1BT
NOMESCO Finland
Blockage of nerv with X-ray guidance
+∞
10.4
10
*
ZXA05
NOMESCO Finland
Left side
1.5
10.4
429
3105
N06AB06
ATC
sertraline; oral
1.8
10.4
197
1169
L04
ICPC
Chest symptom/complaint
2.1
10.4
110
527
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.1
10.4
119
590
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
10.3
253
1619
G43.8
ICD-10 Finland
Other migraine
4.7
10.3
34
74
A11
ICPC
Chest pain NOS
2.0
10.3
136
714
L05
ICPC
Flank/axilla symptom/complaint
2.3
10.3
97
441
G57.1
ICD-10 Finland
Meralgia paraesthetica
5.8
10.3
28
49
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
9.6
10.3
20
21
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
10.2
106
503
SXA20
NOMESCO Finland
Local application of medicine to mouth
2.2
10.2
106
504
164
Kela drug reimbursment
Fingolimod
13.2
10.2
17
13
A03
ICPC
Fever
1.6
10.1
260
1684
C09CA06
ATC
candesartan; oral
1.5
10.1
383
2724
U02
ICPC
Urinary frequency/urgency
1.7
10.1
241
1529
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.4
10.1
85
367
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
4.5
10.1
34
76
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
8.5
10.0
21
25
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.0
10.0
130
678
J01FA15
ATC
telithromycin; oral
1.8
10.0
187
1105
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.8
10.0
41
110
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
10.0
614
4795
M77.4
ICD-10 Finland
Metatarsalgia
2.2
10.0
103
489
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
6.1
10.0
26
43
R10.2
ICD-10 Finland
Pelvic and perineal pain
3.4
10.0
46
136
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
9.9
213
1313
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
9.9
341
2373
A02BC04
ATC
rabeprazole; oral
1.8
9.9
161
910
L04AA27
ATC
fingolimod; oral
16.8
9.9
15
9
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.1
9.8
111
547
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.4
9.8
80
338
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.8
707
5669
M01AC01
ATC
piroxicam; systemic, rectal
1.6
9.8
237
1508
N07BC02
ATC
methadone; systemic
20.1
9.8
14
7
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
9.8
273
1805
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
9.7
409
2967
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
9.7
216
1344
N02CC02
ATC
naratriptan; oral
3.2
9.7
49
155
A29
ICPC
General symptom/complaint other
1.7
9.7
193
1163
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
3.8
9.7
40
108
G04BD09
ATC
trospium; oral
2.8
9.7
61
223
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.6
9.7
27
49
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
55.2
9.6
11
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.7
9.6
65
248
SPAT1097
SPAT
Recording of ECG
1.6
9.6
246
1592
K14.60
ICD-10 Finland
Glossopyrosis
8.4
9.6
20
24
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.8
9.5
158
897
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.6
9.5
69
275
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
9.5
186
1115
R4110
NOMESCO Finland
Physiotherapy
1.4
9.5
455
3388
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.3
9.5
84
371
N04BB01
ATC
amantadine; oral
3.8
9.5
39
105
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.4
9.5
75
313
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
9.5
182
1085
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.1
9.4
49
159
R49.08
ICD-10 Finland
Other specified dysphonia
3.0
9.4
52
176
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
2.3
9.4
83
366
D06
ICPC
Abdominal pain localized other
1.8
9.4
148
828
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.1
9.4
50
165
G51.3
ICD-10 Finland
Clonic hemifacial spasm
+∞
9.4
9
*
R20.3
ICD-10 Finland
Hyperaesthesia
21.8
9.3
13
6
M02AA10
ATC
ketoprofen; topical
1.6
9.3
280
1884
EMAK
NOMESCO Finland
NA
2.4
9.3
77
329
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
10.7
9.3
17
16
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.2
9.3
88
403
R06AX13
ATC
loratadine; oral
1.6
9.3
266
1772
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
3.5
9.2
41
118
H02.3
ICD-10 Finland
Blepharochalasis
2.0
9.2
119
618
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
3.0
9.2
50
168
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
9.1
106
530
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.5
9.1
336
2371
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.0
9.1
50
169
G53.0
ICD-10 Finland
Postzoster neuralgia
7.1
9.0
21
30
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.1
9.0
97
468
UJD02
NOMESCO Finland
Gastroscopy
2.2
8.9
86
397
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
8.9
140
780
G58.0
ICD-10 Finland
Intercostal neuropathy
18.7
8.9
13
7
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
8.9
104
520
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
8.9
83
377
R01AD11
ATC
triamcinolone; nasal
1.8
8.9
165
973
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.3
8.9
80
358
TAC00
NOMESCO Finland
Peripheral nerve block
12.6
8.9
15
12
353
Kela drug reimbursment
Cladribine and fingolimod
12.6
8.9
15
12
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
8.8
502
3855
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
2.8
8.8
54
196
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.8
8.8
150
859
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.7
8.8
181
1104
S80.0
ICD-10 Finland
Contusion of knee
2.0
8.8
114
597
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
8.8
691
5603
R05FB02
ATC
cough suppressants and expectorants
1.4
8.8
691
5604
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
3.0
8.7
47
157
R12
ICD-10 Finland
Heartburn
1.9
8.6
123
666
J45
ICD-10 Finland
Asthma
1.7
8.6
166
990
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.4
8.6
69
290
D01
ICPC
Abdominal pain/cramps general
1.7
8.6
184
1130
N89
ICPC
Migraine
2.6
8.6
59
228
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.3
8.6
78
350
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.3
8.6
42
131
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
8.6
486
3727
P06
ICPC
Sleep disturbance
1.7
8.5
160
946
H16.0
ICD-10 Finland
Corneal ulcer
2.3
8.5
78
352
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
9.0
8.5
17
19
XF402
NOMESCO Finland
ECG with work load test
1.7
8.5
178
1090
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
8.5
256
1724
TAC99
NOMESCO Finland
Other blockade for chronic pain
6.4
8.5
21
33
T78.4
ICD-10 Finland
Allergy, unspecified
2.1
8.5
89
425
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.4
8.4
66
276
C01CA24
ATC
epinephrine; parenteral
2.0
8.4
109
570
K04
ICPC
Palpitations/awareness of heart
2.1
8.4
93
454
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
8.4
132
739
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.8
8.4
132
740
ZXD20
NOMESCO Finland
Day surgery
1.6
8.4
221
1442
N06AX03
ATC
mianserin; oral
2.1
8.4
91
443
R03AC03
ATC
terbutaline; inhalant
1.6
8.3
243
1623
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
8.3
158
937
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.0
8.3
100
508
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
4.6
8.3
27
59
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.7
8.2
164
988
SPAT1104
SPAT
Monitoring of emergency patient
1.9
8.2
111
587
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
8.2
157
935
G04BD12
ATC
mirabegron; oral
1.7
8.2
167
1013
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
14.5
8.2
13
9
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.1
8.2
92
454
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
8.2
134
761
K14.61
ICD-10 Finland
Glossodynia
5.2
8.2
24
47
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.0
8.1
96
483
H53.4
ICD-10 Finland
Visual field defects
3.0
8.1
44
148
R35
ICD-10 Finland
Polyuria
2.0
8.1
102
526
F29
ICPC
Eye symptom/complaint other
1.8
8.1
142
824
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
3.3
8.1
39
121
K07.52
ICD-10 Finland
Malocclusion due to abnormal swallowing
17.2
8.1
12
7
TEG00
NOMESCO Finland
Punction of mandibular joint
22.1
8.0
11
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
8.0
180
1125
X58
ICD-10 Finland
Exposure to other specified factors
1.6
8.0
211
1375
J35.0
ICD-10 Finland
Chronic tonsillitis
2.1
8.0
90
443
K03.80
ICD-10 Finland
Irradiated enamel
2.1
8.0
90
443
SBA00
NOMESCO Finland
Microbiological examinations
2.7
8.0
52
197
A08
ICPC
Swelling
2.2
7.9
74
338
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.1
7.9
41
134
U01
ICPC
Dysuria/painful urination
1.8
7.9
130
740
SFA00
NOMESCO Finland
Small filling
1.6
7.8
220
1457
R03AC12
ATC
salmeterol; inhalant
2.2
7.8
78
368
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.6
7.8
52
200
D06BB03
ATC
aciclovir; topical
2.0
7.8
91
456
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.1
7.8
84
406
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
7.8
125
707
R06.5
ICD-10 Finland
Mouth breathing
1.8
7.7
130
742
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.7
7.7
32
88
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
7.7
185
1173
S20.2
ICD-10 Finland
Contusion of thorax
2.2
7.7
79
374
J30.0
ICD-10 Finland
Vasomotor rhinitis
2.8
7.7
46
165
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
45.1
7.7
9
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.1
7.7
82
397
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
3.5
7.7
34
99
J01.1
ICD-10 Finland
Acute frontal sinusitis
3.5
7.7
34
99
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
5.6
7.7
21
38
N05CD07
ATC
temazepam; oral
1.6
7.6
219
1456
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
7.6
131
756
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.8
7.6
47
173
G56.3
ICD-10 Finland
Lesion of radial nerve
18.4
7.6
11
6
R1250
NOMESCO Finland
Evaluation of functional capability
2.9
7.6
44
154
J04.0
ICD-10 Finland
Acute laryngitis
2.5
7.6
59
244
N06BA07
ATC
modafinil; oral
11.9
7.6
13
11
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
7.6
62
264
H02
ICPC
Hearing complaint
1.6
7.6
188
1205
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.7
7.6
156
951
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
7.5
814
6872
J01
ICD-10 Finland
Acute sinusitis
2.0
7.5
89
449
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
7.5
157
960
SPAT1211
SPAT
Application of soft bandage
1.7
7.5
142
846
D07AA02
ATC
hydrocortisone; topical
1.5
7.5
223
1497
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.3
7.5
67
299
R52.0
ICD-10 Finland
Acute pain
2.5
7.4
55
222
G01AF05
ATC
econazole; vaginal
1.7
7.4
155
948
H29
ICPC
Ear symptom/complaint other
1.7
7.4
166
1034
G58.8
ICD-10 Finland
Other specified mononeuropathies
80.4
7.4
8
*
EB1WA
NOMESCO Finland
NA
6.5
7.4
18
28
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
6.5
7.4
18
28
-50
ICPC
Medication/prescr/renewal
2.1
7.3
79
385
Z50.1
ICD-10 Finland
Other physical therapy
1.9
7.3
96
504
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.7
7.3
139
830
N06AX12
ATC
bupropion; oral
2.0
7.3
88
449
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.7
7.3
47
176
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
7.3
454
3525
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
1.9
7.3
102
550
N28
ICPC
Limited function/disability (N)
3.6
7.3
31
88
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.1
7.3
78
377
M54.8
ICD-10 Finland
Other dorsalgia
2.2
7.3
71
331
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.5
7.2
54
220
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
5.2
7.2
21
41
ZXE00
NOMESCO Finland
One hour or less
1.3
7.2
689
5709
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
15.8
7.2
11
7
N06AB05
ATC
paroxetine; oral
1.9
7.2
109
602
H01.0
ICD-10 Finland
Blepharitis
2.0
7.2
91
470
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.6
7.2
50
195
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.7
7.2
46
172
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.0
7.2
89
460
XQ802
NOMESCO Finland
Epicutan test
2.2
7.2
70
325
EGA05
NOMESCO Finland
Rinsing of mandipular joint
30.1
7.1
9
*
TAD02
NOMESCO Finland
Sympathetic block of ganglion stellatum
30.1
7.1
9
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.8
7.1
22
46
R60.0
ICD-10 Finland
Localized oedema
1.6
7.1
176
1128
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
7.1
293
2108
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
2.4
7.1
57
242
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
20.1
7.1
10
5
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.6
7.1
194
1273
F34.1
ICD-10 Finland
Dysthymia
2.3
7.1
62
273
B02.8
ICD-10 Finland
Zoster with other complications
6.6
7.1
17
26
N93
ICPC
Carpal tunnel syndrome
7.9
7.1
15
19
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
7.1
128
751
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.4
7.1
56
235
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
8.8
7.0
14
16
C03CA01
ATC
furosemide; systemic
1.4
7.0
460
3601
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.9
7.0
98
528
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
7.0
100
543
Z00.8
ICD-10 Finland
Other general examinations
1.8
7.0
113
639
B02AA02
ATC
tranexamic acid; systemic
1.5
7.0
274
1954
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.8
7.0
109
608
S14
ICPC
Burn/scald
2.4
7.0
56
238
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.7
6.9
155
966
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
6.9
78
385
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.9
201
1340
R33
ICD-10 Finland
Retention of urine
1.8
6.9
107
598
1410
FHL
Laparoscopy
2.3
6.9
58
251
A99
ICPC
Disease/condition unspecnature/site
1.7
6.9
130
772
C10AX09
ATC
ezetimibe; oral
1.6
6.9
158
991
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.0
6.9
81
410
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
5.5
6.9
19
35
F45.0
ICD-10 Finland
Somatization disorder
7.5
6.9
15
20
U05
ICPC
Urination problems other
2.1
6.9
74
362
N06AX17
ATC
milnacipran; oral
3.7
6.9
28
77
R03BB04
ATC
tiotropium bromide; inhalant
1.6
6.9
153
957
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
6.8
60
265
D19
ICPC
Teeth/gum symptom/complaint
1.4
6.8
435
3388
B01AB05
ATC
enoxaparin; parenteral
1.3
6.8
509
4064
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.1
6.8
34
110
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.6
6.8
172
1111
S29
ICPC
Skin symptom/complaint other
1.5
6.7
261
1855
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.2
6.7
67
314
R06AX22
ATC
ebastine; oral
1.4
6.7
298
2180
G57.0
ICD-10 Finland
Lesion of sciatic nerve
22.6
6.7
9
*
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
3.9
6.7
25
64
M01AB51
ATC
indometacin, combinations; oral, rectal
2.5
6.7
48
194
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
2.6
6.7
45
176
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.0
6.6
36
123
R06AX26
ATC
fexofenadine; oral
1.8
6.6
108
614
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.7
6.6
144
894
R08
ICPC
Nose symptom/complaint other
2.4
6.6
54
233
K05.0
ICD-10 Finland
Acute gingivitis
2.7
6.6
43
163
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.7
6.6
43
163
R25.2
ICD-10 Finland
Cramp and spasm
2.8
6.6
39
140
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.3
6.6
59
265
M50.9
ICD-10 Finland
Cervical disc disorder, unspecified
5.9
6.6
17
29
J01FA01
ATC
erythromycin; systemic
1.5
6.6
233
1623
M01AX05
ATC
glucosamine; oral
1.4
6.6
337
2527
XF404
NOMESCO Finland
Ambulatory ECG
1.6
6.6
150
942
H02AB09
ATC
hydrocortisone; systemic
2.7
6.6
41
153
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
4.6
6.6
21
46
J45.8
ICD-10 Finland
Mixed asthma
2.3
6.6
54
234
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.6
6.6
44
171
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.9
6.6
25
65
D06BX01
ATC
metronidazole; topical
1.6
6.6
182
1200
A02BDXX
ATC
NA
2.2
6.6
66
312
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
4.3
6.5
22
51
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
10.0
6.5
12
12
H02.2
ICD-10 Finland
Lagophthalmos
10.0
6.5
12
12
C03DA01
ATC
spironolactone; oral
1.6
6.5
168
1087
K05.08
ICD-10 Finland
Another acute gingivitis
2.7
6.5
42
157
M01AG01
ATC
mefenamic acid; oral
2.4
6.5
53
228
ZXD35
NOMESCO Finland
Usual procedure
2.3
6.5
58
259
SPAT1229
SPAT
Assessment of need for aid
1.7
6.5
126
754
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.1
6.5
23
56
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
5.0
6.5
19
38
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.8
6.5
107
613
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
3.6
6.5
27
76
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
6.5
187
1245
L07
ICPC
Jaw symptom/complaint
3.7
6.5
26
71
H66.9
ICD-10 Finland
Otitis media, unspecified
2.0
6.5
79
405
M75.5
ICD-10 Finland
Bursitis of shoulder
2.6
6.4
43
167
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.8
6.4
99
554
N02CX04
ATC
NA
2.5
6.4
46
186
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.5
6.4
27
77
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
6.4
851
7341
SPAT1050
SPAT
Extensive neurological examination
2.6
6.3
43
169
RS340
NOMESCO Finland
NA
8.2
6.3
13
16
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
5.2
6.3
18
35
N06AA22
ATC
NA
5.2
6.3
18
35
34609
ICD-8 Finland
Migraine, Unspecified
5.2
6.3
18
35
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.4
6.3
49
207
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
6.3
214
1482
C08CA05
ATC
nifedipine; systemic
1.8
6.3
107
619
J01DC02
ATC
cefuroxime; systemic
1.8
6.3
103
587
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.8
6.3
37
133
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
6.3
155
997
S22.3
ICD-10 Finland
Fracture of rib
1.8
6.3
101
571
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
6.3
101
571
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
6.3
92
507
79199
ICD-8 Finland
Headache
3.3
6.3
29
89
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.1
6.3
31
100
SPF30
NOMESCO Finland
Soling for prothesis
2.9
6.3
36
126
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
6.3
251
1800
35701
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Nervi mediani
+∞
6.3
6
*
AAH20
NOMESCO Finland
Decompression of cranial nerve
+∞
6.3
6
*
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
+∞
6.3
6
*
R05DB20
ATC
other cough suppressants - combinations
1.8
6.2
92
508
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.0
6.2
78
406
G04BD04
ATC
oxybutynin; oral, transdermal
1.8
6.2
97
543
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
6.2
56
251
DHA10
NOMESCO Finland
Biopsy of cavity of nose
4.8
6.2
19
40
C07AB02
ATC
metoprolol; systemic
1.4
6.2
343
2604
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.0
6.2
77
397
A05
ICPC
Feeling ill
1.9
6.2
89
484
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
6.2
190
1286
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.6
6.2
175
1161
L50.9
ICD-10 Finland
Urticaria, unspecified
2.1
6.2
62
296
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
2.5
6.2
45
184
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
2.4
6.2
50
213
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.7
6.2
123
746
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
6.3
6.2
15
24
G04CA02
ATC
tamsulosin; oral
1.4
6.2
259
1872
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
6.2
211
1464
N41.1
ICD-10 Finland
Chronic prostatitis
3.3
6.1
28
85
P01BA02
ATC
hydroxychloroquine; oral
1.6
6.1
136
849
R19.5
ICD-10 Finland
Other faecal abnormalities
3.2
6.1
30
96
P74
ICPC
Anxiety disorder/anxiety state
2.3
6.1
51
223
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
6.1
212
1472
R83
ICPC
Respiratory infection other
1.4
6.1
374
2888
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.2
6.1
29
91
R03BC03
ATC
nedocromil; inhalant
1.7
6.1
121
734
N06
ICPC
Sensation disturbance other
4.0
6.1
22
55
N06AG02
ATC
moclobemide; oral
1.9
6.1
80
423
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
8.6
6.1
12
14
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.1
6.0
63
305
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
6.0
157
1023
4225
FHL
Exploratory buccal opening, includes polyps and cyst removal
10.0
6.0
11
11
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
6.0
437
3465
N05AB04
ATC
prochlorperazine; systemic, rectal
2.4
6.0
47
199
R03AC13
ATC
formoterol; inhalant
1.9
6.0
82
440
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.5
6.0
26
76
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
5.2
6.0
17
33
K11.70
ICD-10 Finland
Hypoptyalism
5.2
6.0
17
33
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.1
6.0
21
51
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.5
6.0
205
1422
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
230
56
45.47
307.65
2.2
3.2
umol/l
27.1
29.4
0.80
192
39
(3013707) Erythrocyte sedimentation rate by Westergren method
1803
13807
2.37
64.92
5.2
3.8
mm/h
11.2
12.4
3.70
1684
12756
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
73
77
9.76
62.38
2.3
2.4
umol/l
61.1
54.8
0.59
60
57
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1312
9023
2.04
60.38
6.3
6.4
mmol/l
1.2
1.2
0.45
1112
7600
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
891
5347
2.08
59.60
2.6
2.0
u/l
132.2
215.1
3.74
830
5023
(3013826) Glucose [Moles/volume] in Serum or Plasma
1466
10531
2.06
59.33
5.1
4.5
mmol/l
6.4
6.6
5.22
1405
9812
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1215
8180
2.02
58.76
5.6
5.6
mmol/l
1.2
1.2
1.15
1105
7381
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1829
14332
2.30
58.42
7.7
7.3
u/l
77.5
78.0
0.21
1716
13465
(3019198) Lymphocytes [#/volume] in Blood
1321
9404
1.94
51.68
6.2
5.6
e9/l
1.9
1.9
0.12
1168
8250
(3006315) Basophils [#/volume] in Blood
1297
9178
1.94
51.65
6.2
5.6
e9/l
0.0
0.0
0.38
1124
7885
(3001604) Monocytes [#/volume] in Blood
1293
9145
1.93
51.52
6.2
5.6
e9/l
0.6
0.6
0.93
1118
7851
(3013115) Eosinophils [#/volume] in Blood
1330
9500
1.94
51.39
6.3
5.8
e9/l
0.2
0.2
0.08
1174
8285
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
888
5592
1.95
49.65
2.7
2.4
u/l
56.5
57.6
0.21
820
5141
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1014
6710
1.91
48.52
4.2
3.4
ng/l
24.9
47.6
2.77
680
4406
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1313
9477
1.89
47.61
5.5
6.1
umol/l
9.5
11.2
11.12
1230
8975
(3018010) Neutrophils/100 leukocytes in Blood
1228
8753
1.85
45.53
6.1
5.7
%
56.5
57.3
1.76
1138
8179
(3031040) Bacteria [#/volume] in Urine by Automated count
1588
12289
1.92
45.28
6.1
4.4
e6/l
1628.4
2051.5
0.12
30
177
(3019069) Monocytes/100 leukocytes in Blood
1212
8630
1.85
44.82
6.7
6.0
%
8.5
8.5
0.05
1125
8068
(3013650) Neutrophils [#/volume] in Blood by Automated count
1433
10749
1.87
44.80
8.1
8.9
e9/l
4.0
4.1
0.66
1251
9347
(3006504) Eosinophils/100 leukocytes in Blood
1207
8587
1.84
44.73
6.3
5.7
%
2.8
2.8
0.32
1115
7990
(3032080) INR in Blood by Coagulation assay
1035
7039
1.85
44.21
9.0
9.1
inr
1.2
1.2
1.27
312
2065
(3022096) Basophils/100 leukocytes in Blood
1178
8341
1.84
44.11
6.3
5.8
%
0.7
0.7
0.26
1090
7761
(3002030) Lymphocytes/100 leukocytes in Blood
1236
8885
1.84
44.01
6.4
5.8
%
28.8
28.0
1.85
1139
8268
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
559
3191
1.99
40.11
1.4
1.3
iu/ml
25.6
32.9
0.98
165
1023
(42870588) Differential panel, method unspecified - Blood
910
6127
1.80
38.72
5.8
5.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
273
1187
2.47
38.51
2.5
2.4
au/ml
15.3
19.5
—
10
76
(3037467) Urinalysis macro (dipstick) panel - Urine
1603
12740
1.83
38.45
5.4
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
446
2398
2.06
37.55
1.4
1.3
titre
568.3
567.2
0.00
92
517
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
526
3024
1.96
36.55
1.4
1.2
u/ml
6.2
12.8
1.82
194
1192
(3036481) Cortisol [Moles/volume] in Serum or Plasma
333
1648
2.19
34.59
2.2
2.1
nmol/l
372.1
374.5
0.08
298
1507
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
247
1077
2.45
34.49
1.4
1.3
au/ml
14.5
34.2
—
7
54
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2112
18780
2.37
32.23
18.8
13.3
mg/l
19.7
23.5
7.17
1808
14725
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1034
7497
1.68
31.94
2.1
1.9
pmol/l
97.1
95.4
0.44
509
3765
(3024561) Albumin [Mass/volume] in Serum or Plasma
1070
7837
1.68
31.73
4.5
4.6
g/l
36.2
35.5
4.44
992
7278
(3018418) pH of Serum or Plasma
799
5431
1.72
31.23
3.5
3.8
ph
7.4
7.4
0.07
166
1021
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1518
12232
1.70
30.77
3.7
3.0
u/l
51.9
45.7
1.85
1415
11385
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1075
7930
1.66
30.66
2.5
2.2
nmol/l
78.1
78.4
0.12
955
7132
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
633
4048
1.77
30.60
1.8
1.8
mg/l
0.8
1.1
3.03
457
3063
(3019550) Sodium [Moles/volume] in Serum or Plasma
2144
19306
2.43
29.72
21.3
15.1
mmol/l
139.2
139.7
12.14
2117
18792
(3026008) Bacteria identified in Urine by Culture
831
5775
1.68
29.52
3.6
3.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2144
19366
2.39
28.45
21.1
15.2
mmol/l
4.0
4.0
0.05
2113
18817
(3002582) Erythrocytes [#/volume] in Urine
789
5472
1.67
27.88
3.7
3.0
e6/l
46.8
90.4
1.23
618
4132
(3000850) Epithelial cells [#/volume] in Urine
586
3773
1.74
27.16
2.8
2.5
e6/l
6.5
6.6
0.03
514
3280
(3018095) Leukocytes [#/volume] in Urine
901
6504
1.63
26.96
4.4
3.5
e6/l
77.7
111.4
0.94
673
4485
(3018677) aPTT in Platelet poor plasma by Coagulation assay
442
2639
1.83
26.40
2.0
2.1
s
28.9
29.9
2.87
424
2558
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1742
14815
1.70
26.31
5.2
4.1
pmol/l
14.5
14.7
3.28
1603
13519
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
56
115
4.97
25.82
1.2
1.2
mg/l
41.7
35.0
0.34
47
95
(3035350) Ketones [Presence] in Urine by Test strip
1170
9056
1.59
25.78
4.5
3.6
estimate
0.0
0.0
0.00
234
1659
(3021601) Nitrite [Presence] in Urine by Test strip
1166
9088
1.57
24.42
5.9
4.9
estimate
0.0
0.0
0.50
238
1675
(3015171) Extractable nuclear Ab [Units/volume] in Serum
168
719
2.44
24.27
1.3
1.2
u/ml
2.0
1.0
0.28
16
57
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
117
418
2.89
24.22
1.4
1.3
mg/l
476.2
501.7
0.28
110
392
(3026782) Osmolality of Urine
547
3552
1.71
24.19
2.9
2.6
mosm/kgh2o
528.2
539.4
0.57
466
2993
(36304419) Bacteria [Presence] in Urine
707
4907
1.63
24.19
3.6
2.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
520
3332
1.72
24.14
1.8
1.7
nmol/l
1200.8
1184.2
0.14
382
2471
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
721
5034
1.63
24.06
2.9
3.0
ng/l
980.0
1391.1
3.22
612
4286
(3009261) Glucose [Presence] in Urine by Test strip
1174
9188
1.56
23.97
4.6
3.6
estimate
0.0
0.0
1.08
237
1658
(3044290) Cell count panel - Cerebral spinal fluid
101
335
3.11
23.82
1.3
1.4
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
52
110
4.81
23.18
1.2
1.1
mg/l
262.3
238.6
0.27
46
95
(3003396) Base excess in Arterial blood by calculation
337
1926
1.88
22.89
6.1
7.9
mmol/l
1.0
1.2
0.49
268
1502
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1964
17476
1.80
22.86
6.2
4.8
mu/l
2.9
2.2
0.24
1825
16051
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
820
5969
1.58
22.67
3.3
3.1
u/l
29.6
34.2
1.74
774
5665
(3021960) Folate [Moles/volume] in Serum or Plasma
616
4189
1.64
22.60
1.6
1.5
nmol/l
19.6
20.9
1.60
544
3573
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1058
8163
1.54
22.53
3.0
2.7
ug/l
103.0
116.8
1.41
978
7545
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
50
105
4.84
22.48
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
106
375
2.91
22.34
1.5
1.5
e6/l
390.4
1425.7
0.73
85
299
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
106
375
2.91
22.34
1.4
1.5
e6/l
10.6
12.5
0.15
80
281
(3027801) Oxygen [Partial pressure] in Arterial blood
336
1934
1.86
22.28
6.1
7.9
kpa
13.4
12.5
1.67
317
1843
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
336
1934
1.86
22.28
6.1
7.9
kpa
5.1
5.1
0.20
318
1840
(3007853) Bacteria identified in Skin by Aerobe culture
345
2006
1.85
22.14
1.9
1.7
—
—
—
0
0
(4027681)
46
93
5.03
21.62
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
709
5034
1.59
21.60
3.6
3.0
e6/l
0.3
0.5
2.78
552
3746
(40768797) Stomach Pathology biopsy report
412
2545
1.75
21.55
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
518
3411
1.67
21.40
4.5
3.5
ng/l
323.7
333.8
0.03
354
2572
(3026493) Urate [Moles/volume] in Serum or Plasma
654
4564
1.60
21.39
2.4
2.5
umol/l
5399.0
5774.2
0.07
545
3958
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
103
369
2.87
21.23
1.3
1.3
mmol/l
3.6
3.8
1.03
93
346
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
449
2872
1.70
20.62
2.1
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
857
6439
1.52
19.89
3.2
3.4
mmol/l
2.3
2.4
1.73
744
5652
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
55
138
4.06
19.80
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
584
4033
1.60
19.70
1.4
1.2
u/ml
1.1
1.5
0.54
162
1076
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
161
743
2.25
19.55
1.9
1.9
u/l
38.4
39.7
0.43
143
657
(3029937) Albumin [Presence] in Urine by Test strip
670
4816
1.55
18.85
5.2
4.0
estimate
0.0
0.0
0.88
240
1639
(3019150) Specific gravity of Urine by Refractometry
553
3854
1.57
17.66
5.0
4.0
kg/l
1.0
1.0
0.41
69
536
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
42
94
4.53
17.53
1.1
1.1
u/l
1.1
1.2
0.44
20
57
(3005719) IgG [Mass/volume] in Serum or Plasma
235
1299
1.90
17.50
2.5
2.7
g/l
9.4
10.6
4.62
215
1173
(3005322) IgE [Units/volume] in Serum or Plasma
216
1163
1.95
17.41
1.4
1.3
u/ml
145.6
198.6
0.57
202
1068
(3012095) Magnesium [Moles/volume] in Serum or Plasma
429
2830
1.63
17.20
3.0
3.3
mmol/l
0.8
0.8
1.95
389
2636
(3011397) Hemoglobin [Presence] in Urine by Test strip
597
4274
1.53
16.77
4.5
3.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
645
4696
1.52
16.75
4.3
4.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
574
4077
1.54
16.71
4.5
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
507
3517
1.56
16.37
1.6
1.4
g/l
2.1
2.4
3.28
307
2135
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2000
18275
1.68
16.36
5.0
4.4
mmol/l
5.8
5.9
0.30
1828
16634
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2150
20074
1.95
16.16
12.9
9.9
u/l
25.1
25.0
0.13
2087
19383
(3048689) Calprotectin [Mass/mass] in Stool
344
2177
1.68
16.14
1.9
2.2
ug/g
129.2
118.8
0.17
274
1721
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1900
17164
1.59
16.05
6.0
5.3
mmol/mol
39.1
39.4
0.83
1762
15873
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1065
8621
1.43
15.80
4.3
3.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
282
1700
1.75
15.77
6.6
8.5
%
95.9
95.6
0.29
267
1638
(3022217) INR in Platelet poor plasma by Coagulation assay
355
2279
1.66
15.74
20.3
24.7
inr
1.2
1.4
2.57
57
308
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
118
524
2.32
15.70
1.7
1.6
g/l
0.2
0.2
0.08
112
496
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
888
6965
1.45
15.57
4.9
3.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
628
4611
1.50
15.44
2.4
2.1
mg/l
2.9
3.0
0.41
545
3906
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
120
542
2.28
15.35
1.7
1.6
g/l
1.2
1.2
1.11
113
514
(3002173) Hemoglobin [Mass/volume] in Arterial blood
264
1576
1.76
15.26
6.9
9.0
g/l
123.9
119.9
2.67
251
1516
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
30
57
5.32
15.14
1.1
1.1
ng/l
1123.5
92.1
—
6
13
(3022145) Colonoscopy Study observation
318
2003
1.68
15.13
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
317
2002
1.68
14.93
2.1
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1028
8326
1.42
14.91
9.3
9.0
e9/l
0.0
0.0
0.83
829
6759
(40758558) Short blood count panel - Blood
643
4773
1.48
14.88
6.3
6.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
444
3076
1.55
14.20
3.1
2.6
e6/l
1.2
1.3
0.28
270
1692
(3003327) Ova and parasites identified in Stool by Light microscopy
118
552
2.20
13.89
1.7
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
44
123
3.63
13.69
1.6
1.8
—
—
—
0
0
(3013512) EKG study
686
5226
1.44
13.66
4.2
3.6
—
—
—
0
0
(4010399)
213
1237
1.79
13.49
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1944
17852
1.55
13.17
15.9
12.4
ml/min/173m2
82.4
80.7
3.04
1681
14693
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
208
1212
1.79
13.02
3.0
3.4
pmol/l
4.4
4.5
0.41
192
1073
(3044640) Blood type and Crossmatch panel - Blood
755
5896
1.42
12.97
2.4
2.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
53
173
3.11
12.95
1.3
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
165
896
1.91
12.94
6.5
10.0
mmol/l
24.3
24.4
0.19
153
842
(3033658) Prothrombin time (PT) actual/Normal
625
4725
1.44
12.83
4.2
3.7
%
93.7
91.6
1.33
604
4595
(3025941) Bacteria identified in Stool by Culture
181
1021
1.84
12.61
1.3
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
312
2044
1.61
12.61
2.3
2.6
umol/l
5.4
8.1
4.04
255
1781
(40761511) CBC panel - Blood by Automated count
2095
19627
1.69
12.54
17.1
12.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
99
453
2.24
12.32
2.1
2.0
mg/l
9.1
11.8
2.38
92
413
(3026389) Candida sp identified in Specimen by Organism specific culture
61
222
2.79
12.32
1.5
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
389
2700
1.53
12.18
2.2
2.3
umol/l
12.6
13.2
0.89
354
2512
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
305
2013
1.59
11.92
2.1
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
445
3196
1.49
11.80
1.6
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
523
3878
1.45
11.76
1.7
1.6
pmol/l
88264489.0
32534677.6
0.73
409
3212
(3004789) Transferrin [Mass/volume] in Serum or Plasma
357
2459
1.53
11.54
2.2
2.3
g/l
2.4
2.3
1.25
326
2288
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
15
18
8.38
11.49
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1487
13131
1.37
11.38
4.1
3.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
178
1031
1.79
11.37
7.0
7.5
mmol/l
25.0
24.6
0.87
160
959
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
36
101
3.60
11.18
1.2
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
322
2190
1.55
11.00
5.7
6.9
mmol/l
104.0
104.3
0.57
307
2144
(3014111) Lactate [Moles/volume] in Serum or Plasma
240
1524
1.64
10.96
5.5
7.0
mmol/l
1.3
1.3
0.31
231
1466
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
234
1477
1.65
10.94
2.6
2.4
ug/l
6.0
6.8
0.28
191
1298
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
405
2897
1.48
10.88
3.4
2.7
e6/l
4.7
3.2
1.04
234
1526
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
99
477
2.12
10.87
1.3
1.3
u/ml
15.6
7.9
0.24
14
91
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1363
11923
1.35
10.79
3.5
3.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
98
473
2.12
10.72
1.3
1.2
u/ml
12.2
8.5
—
9
52
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
66
270
2.49
10.61
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33
91
3.66
10.52
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
120
629
1.96
10.48
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
314
2147
1.53
10.45
1.5
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
108
549
2.01
10.29
1.7
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
174
1032
1.74
10.25
1.9
1.7
g/l
1.1
1.4
1.01
162
934
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
79
356
2.26
10.25
1.3
1.3
u/ml
1.1
1.9
—
6
30
(3019225) pH of Specimen
269
1787
1.57
10.17
4.2
3.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
48
171
2.85
10.13
1.2
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
172
1024
1.73
10.00
3.0
3.3
kpa
5.2
5.2
0.34
160
945
(40768804) Tissue Pathology biopsy report
951
7954
1.33
9.91
2.2
2.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
264
1762
1.56
9.78
2.9
2.3
u/l
37.9
37.8
0.01
223
1503
(3000570) Elastase.pancreatic [Mass/mass] in Stool
102
518
2.01
9.76
1.3
1.4
ug/g
277.0
294.6
0.31
58
285
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
57
227
2.55
9.72
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
175
1057
1.71
9.66
1.9
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
469
3520
1.42
9.66
2.9
3.0
mmol/l
2.4
2.5
1.80
408
3095
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
200
1254
1.65
9.59
1.6
1.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
279
1898
1.53
9.48
3.1
4.4
u/l
242.4
248.5
0.27
259
1799
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
88
428
2.10
9.47
1.3
1.3
—
27.4
—
0
7
(3003181) Sodium [Moles/volume] in Urine
71
317
2.28
9.44
1.2
1.3
mmol/l
68.4
60.5
0.94
59
256
(3009343) pH of Capillary blood
168
1013
1.71
9.34
2.9
3.3
ph
7.4
7.4
0.40
23
125
(3020961) Endomysium IgA Ab [Titer] in Serum
147
855
1.77
9.28
1.1
1.1
titre
—
158.1
—
0
18
(3028679) Herpes simplex virus Ab [Presence] in Serum
31
90
3.48
9.20
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
323
2289
1.48
9.00
2.3
2.4
%
21.6
22.9
0.98
279
1978
(3004616) Nuclear Ab [Presence] in Serum
53
212
2.54
8.98
1.4
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
36
117
3.11
8.95
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
117
642
1.87
8.94
2.0
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
174
1075
1.67
8.84
7.0
9.3
%
94.3
93.9
0.50
174
1068
(3013139) Helicobacter pylori Ag [Presence] in Stool
192
1219
1.63
8.77
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
316
2243
1.47
8.72
4.5
5.2
mmol/l
1.1
1.0
0.95
288
2069
(40761535) Cells panel - Urine sediment
221
1457
1.57
8.62
3.7
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
160
975
1.69
8.57
2.9
3.2
mmol/l
1.8
1.8
0.06
122
720
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
388
2.07
8.32
1.3
1.2
u/ml
62.7
38.3
—
9
41
(3014148) Varicella zoster virus Ab [Titer] in Serum
50
202
2.51
8.32
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
309
2208
1.46
8.23
6.7
6.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
567
4495
1.35
8.19
2.4
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
234
1583
1.53
8.14
3.3
3.3
mmol/l
2.1
2.0
0.19
197
1291
(3014765) Yersinia sp identified in Stool by Organism specific culture
103
561
1.87
8.08
1.2
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
33
110
3.03
7.89
1.2
1.1
nmol/l
1.4
3.8
—
5
21
(3027945) Reticulocytes/100 erythrocytes in Blood
268
1878
1.48
7.87
2.1
2.5
%
1.7
1.8
1.41
237
1668
(3012544) pH of Venous blood
239
1637
1.51
7.84
3.5
3.2
—
7.4
—
0
5
(42529406) Shigella sp [Presence] in Stool by Culture
103
567
1.85
7.83
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
102
562
1.85
7.74
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
179
1156
1.59
7.64
2.4
2.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
38
140
2.74
7.61
1.2
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
233
1598
1.51
7.60
3.3
3.2
kpa
5.9
5.8
0.81
225
1551
(40768443) Skin Pathology biopsy report
133
800
1.70
7.50
1.2
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
50
213
2.38
7.46
1.2
1.3
u/ml
33.8
55.0
—
5
15
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
121
713
1.74
7.35
2.1
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
170
1095
1.60
7.34
5.2
5.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
210
1424
1.52
7.23
6.7
8.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
403
1.97
7.19
1.4
1.3
u/l
15.7
12.0
0.87
64
328
(3022313) Gas panel - Capillary blood
122
727
1.72
7.13
3.1
3.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
606
4938
1.31
7.08
4.1
3.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
220
1517
1.50
7.00
3.3
3.6
mmol/l
1.2
1.2
0.33
196
1302
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2001
18973
1.39
6.99
5.3
4.7
mmol/l
2.8
2.8
0.07
1830
17454
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
100
566
1.80
6.99
2.2
2.4
ug/l
281.6
845.7
0.90
94
531
(3007461) Platelets [#/volume] in Blood
2175
20960
1.59
6.94
27.6
19.6
e9/l
255.9
255.7
0.06
2140
20403
(36660697) Celiac disease serology panel - Serum
207
1412
1.51
6.93
1.3
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
31
4.86
6.93
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
202
1371
1.52
6.93
3.3
3.4
ng/l
78.9
84.5
0.49
164
1179
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
21
57
3.71
6.91
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
150
954
1.61
6.84
2.4
2.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
2175
20971
1.58
6.79
27.5
19.6
fl
91.2
91.1
0.27
2157
20656
(3035941) MCH [Entitic mass]
2175
20974
1.58
6.75
27.4
19.5
pg
30.4
30.3
1.75
2157
20658
(3026361) Erythrocytes [#/volume] in Blood
2175
20975
1.58
6.74
27.6
19.6
e12/l
4.4
4.5
0.42
2135
20360
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
16
36
4.47
6.70
1.1
2.0
umol/l
16.7
19.9
0.51
16
36
(3010813) Leukocytes [#/volume] in Blood
2175
20978
1.58
6.70
27.6
19.7
e9/l
6.7
6.7
0.18
2137
20359
(3000963) Hemoglobin [Mass/volume] in Blood
2175
20981
1.58
6.65
27.7
19.7
g/l
134.3
134.0
0.46
2158
20666
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
64
3.46
6.56
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
150
965
1.59
6.53
1.3
1.4
—
—
—
0
0
(4062490)
42
177
2.40
6.46
1.7
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
193
1320
1.50
6.39
2.7
2.6
kpa
4.3
4.6
1.14
187
1274
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
40
166
2.43
6.37
1.5
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1893
17855
1.33
6.35
4.2
3.8
mmol/l
1.4
1.3
4.21
1725
16325
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1965
18636
1.35
6.35
4.8
4.2
mmol/l
4.8
4.8
0.42
1810
17253
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
137
870
1.61
6.30
8.9
11.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
196
1349
1.49
6.30
1.2
1.2
iu/ml
84.4
153.5
2.85
79
518
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
106
630
1.72
6.29
3.3
3.5
mmol/l
25.2
24.9
0.45
99
578
(3024869) Neuronal Ab [Presence] in Serum
14
30
4.69
6.21
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
643
5362
1.28
6.15
3.0
3.0
mmol/l
7.3
7.2
0.17
528
4489
(3042936) Bacteria identified in Isolate by Culture
324
2456
1.37
6.12
2.3
1.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
87
493
1.79
6.09
1.5
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
210
1476
1.46
6.08
3.2
2.9
ng/l
148.9
200.6
1.26
181
1333
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
25
83
3.03
6.07
1.2
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
151
991
1.56
6.05
1.4
1.3
iu/l
34.2
32.0
0.32
129
854
(3045414) Leukocytes [Presence] in Urine
130
825
1.61
6.01
2.1
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
98
578
1.73
5.99
2.4
2.0
u/l
917.2
3880.4
1.79
32
238
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
54
3.54
5.88
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
85
484
1.78
5.87
1.2
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
201
1414
1.46
5.80
2.8
2.6
g/l
66.8
66.5
0.26
187
1291
(3024139) IgG subclass 3 [Mass/volume] in Serum
40
174
2.32
5.77
1.7
1.4
g/l
0.4
0.4
0.13
31
122
(3028192) IgG subclass 2 [Mass/volume] in Serum
40
174
2.32
5.77
1.7
1.4
g/l
2.5
2.9
1.00
31
123
(3027135) IgG subclass 1 [Mass/volume] in Serum
40
174
2.32
5.77
1.7
1.4
g/l
5.8
6.7
1.60
30
122
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
55
273
2.04
5.74
1.4
1.4
u/l
23.5
31.3
0.89
48
224
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
128
822
1.59
5.65
3.4
3.3
mmol/l
24.1
24.2
0.15
111
747
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
37
4.07
5.63
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
55
276
2.02
5.58
1.9
1.6
g/l
0.7
0.8
0.57
45
211
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
70
382
1.86
5.56
1.2
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
36
152
2.39
5.56
1.2
1.2
u/ml
0.0
0.7
1.36
14
63
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
78
442
1.79
5.50
2.0
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
84
488
1.75
5.44
1.1
1.1
u/ml
9.8
5.6
—
6
70
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1944
18506
1.31
5.36
4.8
4.2
mmol/l
1.5
1.5
0.68
1781
17036
(3015235) Bicarbonate [Moles/volume] in Capillary blood
73
409
1.81
5.35
2.3
2.9
mmol/l
24.3
24.9
0.62
62
353
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
108
676
1.63
5.31
5.7
6.5
%
1.7
1.6
0.67
101
627
(3035637) Corticotropin [Mass/volume] in Plasma
43
201
2.16
5.26
1.7
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
46
221
2.10
5.26
1.2
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
27
102
2.67
5.24
2.6
2.3
e6/l
416.4
573.2
0.78
21
85
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
45
215
2.11
5.22
1.3
1.4
pmol/l
333.6
313.9
0.15
34
167
(3020682) Albumin/Creatinine [Ratio] in Urine
630
5328
1.25
5.21
3.9
3.8
mg/mmol
5.8
8.2
1.16
378
3253
(3021387) Prolactin [Units/volume] in Serum or Plasma
98
602
1.66
5.20
2.2
1.6
mu/l
326.2
323.2
0.03
89
549
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
90
541
1.69
5.18
2.9
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
252
1885
1.38
5.16
3.5
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
201
1448
1.42
5.13
2.4
2.5
ml/min/173m2
65.8
66.6
0.11
79
583
(3002385) Erythrocyte distribution width [Ratio]
1679
15733
1.24
5.10
21.3
16.3
%
13.6
13.7
2.62
1654
15379
(3037121) Protein [Mass/volume] in Urine
92
559
1.67
5.09
2.7
3.2
g/l
0.2
0.2
0.60
33
222
(3043409) Potassium [Moles/volume] in Arterial blood
86
516
1.69
5.00
4.0
3.5
mmol/l
3.8
3.9
0.26
79
483
(3012516) Albumin [Mass/volume] in Urine
598
5049
1.25
4.99
3.2
3.1
mg/l
1117.0
309.0
1.58
361
3073
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
57
302
1.91
4.99
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
124
815
1.55
4.99
1.9
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
21
71
2.98
4.98
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
34
148
2.32
4.94
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
32
4.08
4.89
1.1
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
44
214
2.08
4.89
1.5
2.2
mg/l
32.5
25.6
0.26
11
61
(3047181) Lactate [Moles/volume] in Blood
83
497
1.69
4.87
7.4
8.2
mmol/l
1.2
1.3
1.10
76
427
(3020891) Body temperature
108
693
1.59
4.83
4.1
4.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
20
67
3.00
4.83
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
70
401
1.77
4.80
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
70
401
1.77
4.80
1.5
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
67
379
1.79
4.79
1.5
1.6
e6/l
11268.0
13052.5
0.20
48
280
(3007930) Methemoglobin/Hemoglobin.total in Blood
105
671
1.59
4.78
5.9
6.6
%
0.8
0.9
0.34
99
624
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
29
120
2.43
4.72
1.3
1.3
mmol/l
2.0
1.9
0.32
29
112
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
33
3.96
4.71
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
49
252
1.96
4.70
1.2
1.3
nmol/l
0.1
0.5
—
5
17
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
25
97
2.59
4.64
2.6
2.4
e9/l
0.3
0.2
0.82
20
84
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
44
219
2.03
4.62
1.2
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
23
86
2.69
4.58
1.4
1.6
nmol/l
1.4
4.2
1.09
17
70
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
114
752
1.54
4.54
3.2
3.4
%
48.3
48.5
0.02
114
744
(3023520) Reticulocytes [#/volume] in Blood
191
1396
1.40
4.51
2.2
2.6
e9/l
67.1
71.2
0.84
144
1052
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
30
129
2.34
4.50
1.3
1.1
—
2.2
—
0
10
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
44
3.42
4.46
3.5
2.8
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
31
136
2.30
4.45
1.4
1.1
—
59.8
—
0
9
(3017181) Myelocytes/100 leukocytes in Blood
204
1512
1.38
4.44
4.3
4.1
%
1.0
0.9
0.10
60
403
(3021440) Promyelocytes/100 leukocytes in Blood
195
1435
1.39
4.43
4.1
4.2
%
0.2
0.1
0.23
57
365
(3005988) Vibrio sp identified in Specimen by Organism specific culture
43
216
2.01
4.42
1.2
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
34
157
2.18
4.34
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
57
318
1.81
4.30
1.5
1.6
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
25
101
2.49
4.30
1.8
1.4
u/l
5.3
6.6
0.68
20
84
(3024522) Salmonella sp identified in Specimen by Organism specific culture
43
220
1.97
4.21
1.2
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
174
1268
1.40
4.20
2.6
2.8
e9/l
4.0
4.1
0.15
137
996
(3000492) Spirometry study
229
1749
1.34
4.13
1.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
187
1384
1.38
4.12
4.1
3.9
%
0.6
0.7
0.16
38
293
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
19
68
2.81
4.12
2.1
3.2
umol/l
71.3
211.9
1.55
13
42
(3025468) Yersinia sp identified in Specimen by Organism specific culture
42
215
1.97
4.12
1.2
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
42
215
1.97
4.12
1.2
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
61
354
1.74
4.05
2.0
2.5
%
16.5
16.1
0.23
27
173
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
283
2234
1.30
4.05
4.9
4.3
%
32.2
32.9
0.48
202
1473
(3025159) Blasts/100 leukocytes in Blood
183
1355
1.38
4.03
4.1
4.3
%
0.3
0.3
0.08
41
309
(3017143) Hepatitis C virus Ab [Presence] in Serum
245
1899
1.32
4.00
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
576
4951
1.22
3.95
1.7
1.6
mmol/l
1.4
1.4
1.18
461
4185
(3012501) Base excess in Blood by calculation
66
395
1.69
3.94
2.7
4.1
mmol/l
2.2
2.7
1.03
43
268
(3017704) Immunofixation for Urine
22
89
2.49
3.80
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
85
548
1.57
3.79
3.4
3.5
—
—
—
0
0
(4015189)
13
39
3.35
3.76
2.7
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
360
2957
1.26
3.76
1.7
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
41
216
1.91
3.73
1.2
1.3
nmol/l
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
32
154
2.09
3.73
2.6
2.2
e9/l
1.2
1.1
0.35
12
97
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
10
25
4.01
3.70
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
61
2.80
3.69
1.2
1.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
12
6.68
3.67
1.0
1.1
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
14
45
3.12
3.65
1.4
1.6
mu/l
557.4
482.4
0.15
14
45
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
145
1051
1.40
3.64
2.1
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
205
1571
1.33
3.64
4.9
3.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
40
3.26
3.62
1.5
1.9
e6/l
192.0
178.8
—
5
17
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
29
136
2.15
3.61
1.8
1.7
mg/l
2.4
4.0
4.40
29
130
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
43
233
1.86
3.61
1.2
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
147
1074
1.39
3.53
3.2
2.9
g/l
131.2
127.9
1.14
142
1052
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
14
46
3.06
3.53
1.4
1.7
%
73.7
72.9
0.08
14
46
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
117
822
1.45
3.50
2.1
2.3
%
0.7
0.7
0.42
108
796
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
76
488
1.58
3.48
1.2
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
45
251
1.81
3.46
3.8
3.4
%
0.9
1.5
1.02
31
195
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
140
1021
1.40
3.41
1.5
1.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
17
64
2.67
3.39
1.1
1.3
g/l
—
0.4
—
0
7
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
96
655
1.49
3.35
1.8
2.0
ug/l
2.6
1.9
0.23
84
576
(3034274) Bile acid [Moles/volume] in Serum --fasting
36
189
1.92
3.34
1.5
2.1
umol/l
4.3
6.1
0.77
23
134
(1616796) Gas panel - Central venous blood
60
369
1.64
3.29
3.1
3.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
67
426
1.59
3.22
2.5
2.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
47
272
1.74
3.22
1.8
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
47
272
1.74
3.22
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
29
143
2.04
3.21
2.2
2.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
30
150
2.01
3.20
4.1
3.5
%
49.3
54.2
0.29
15
97
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
11
6.38
3.18
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
205
1604
1.30
3.17
2.1
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
52
313
1.68
3.11
1.7
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
39
3.09
3.09
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
106
2.18
3.03
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
182
1.88
3.01
1.8
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
57
355
1.62
3.00
8.7
9.9
mmol/l
10.8
11.3
0.66
50
313
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
21
4.30
2.99
1.0
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
57
356
1.62
2.97
8.7
9.9
mmol/l
104.6
105.3
0.56
50
314
(3028626) Oxygen [Partial pressure] in Capillary blood
57
356
1.62
2.97
2.3
2.7
kpa
8.4
8.1
0.48
51
324
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
57
2.64
2.96
1.0
1.1
—
—
—
0
0
(3010421) pH of Blood
73
484
1.52
2.95
2.8
3.9
ph
7.4
7.4
0.44
64
390
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
67
437
1.55
2.92
1.3
1.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
22
4.10
2.88
1.0
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
89
2.26
2.87
1.3
1.1
u/l
14.1
22.0
0.77
15
66
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
41
2.94
2.86
1.3
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
299
2484
1.23
2.83
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
225
1810
1.27
2.82
2.1
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
621
1.45
2.82
2.6
2.4
g/l
9.5
10.4
1.54
73
534
(3024263) Appearance of Synovial fluid
18
77
2.35
2.82
1.6
2.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
11
36
3.07
2.81
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
41
239
1.73
2.78
1.5
1.5
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
42
2.87
2.75
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
42
2.87
2.75
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
42
2.87
2.75
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
42
2.87
2.75
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
76
518
1.48
2.72
1.7
1.6
iu/ml
0.1
0.1
0.07
23
105
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
452
3924
1.19
2.71
5.0
4.9
ug/l
2.1
3.0
1.58
401
3498
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
105
2.11
2.68
1.4
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
24
3.76
2.67
1.1
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
10
32
3.13
2.64
17.4
6.8
%
69.8
68.6
—
10
27
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
672
1.42
2.63
2.6
2.3
g/l
7.6
7.4
0.52
67
511
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
672
1.42
2.63
2.6
2.3
g/l
3.9
3.8
0.20
65
484
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
672
1.42
2.63
2.6
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
56
360
1.57
2.63
2.0
2.2
g/l
135.6
128.5
1.86
41
263
(4198724)
13
49
2.66
2.62
1.5
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
101
732
1.40
2.62
1.4
1.8
g/l
1.6
1.6
0.22
82
633
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
113
2.05
2.61
1.1
1.1
iu/ml
15.1
10.9
—
6
30
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
80
2.26
2.60
1.1
1.0
miu/ml
1519.5
1615.4
0.10
18
80
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
130
983
1.34
2.60
1.1
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
15
4.68
2.59
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
42
252
1.68
2.59
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
355
1.56
2.55
1.6
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
44
2.74
2.54
2.3
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
44
2.74
2.54
2.3
2.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
45
277
1.64
2.53
1.3
1.2
u/ml
5.2
4.3
—
10
86
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
101
2.09
2.53
1.0
1.0
—
—
—
0
0
(3036489) Thrombin time
94
679
1.40
2.50
1.8
2.0
s
20.6
21.4
0.63
78
597
(4024509)
32
180
1.79
2.47
1.8
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
44
271
1.64
2.47
1.3
1.2
u/ml
2.2
5.3
1.62
14
110
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
116
1.99
2.45
1.1
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
123
1.96
2.45
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
121
914
1.34
2.45
3.6
3.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
57
2.46
2.45
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
51
2.56
2.44
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
272
1.63
2.44
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
59
392
1.52
2.42
2.8
2.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
633
1.41
2.41
2.8
2.4
g/l
3.1
3.1
0.12
67
500
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
110
2.01
2.41
2.8
2.4
e6/l
906.2
748.7
0.43
15
44
(3023419) Bacteria identified in Sputum by Culture
35
205
1.72
2.37
3.2
2.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
17
4.13
2.36
2.0
3.3
u/field
0.7
0.7
—
7
17
(3022621) pH of Urine by Test strip
152
1193
1.29
2.36
3.8
2.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
46
2.62
2.36
1.0
1.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
42
260
1.63
2.33
3.8
5.2
umol/l
360.1
365.8
0.08
36
220
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
49
316
1.56
2.30
4.8
5.5
iu/ml
369.7
426.6
—
7
45
(4034850)
87
630
1.40
2.30
12.9
8.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
45
285
1.59
2.28
1.5
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
148
1.83
2.28
1.1
1.3
mmol/l
6.9
11.6
—
5
39
(3048929) Epstein Barr virus Ab [Presence] in Serum
69
480
1.45
2.28
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
53
2.46
2.27
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
35
208
1.69
2.27
1.5
1.6
—
28.8
—
0
11
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
23
3.49
2.27
1.4
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
23
3.49
2.27
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
72
506
1.44
2.26
1.9
1.9
iu/l
7.7
4.8
0.36
29
178
(3021901) Oxygen saturation in Capillary blood
46
294
1.58
2.25
2.1
2.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
117
894
1.33
2.22
2.0
2.2
nmol/l
12.8
12.2
0.25
104
782
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
60
2.34
2.22
1.8
1.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
9
5.56
2.21
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
16
73
2.20
2.21
2.0
3.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
31
180
1.73
2.19
2.6
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
142
1789
0.78
2.19
1.3
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
24
3.34
2.18
1.4
1.0
—
—
—
0
0
(44813793)
24
129
1.87
2.17
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
77
553
1.41
2.16
1.4
1.3
miu/ml
200.1
230.6
0.29
32
258
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
21
108
1.95
2.15
1.1
1.1
ratio
1.0
1.0
—
6
46
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
50
331
1.52
2.12
1.2
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
23
123
1.88
2.11
1.8
1.9
%
13.9
12.5
—
9
50
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
95
2.01
2.10
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
95
2.01
2.10
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
37
2.71
2.10
1.2
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
10
5.01
2.07
2.0
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
32
191
1.68
2.06
1.5
1.6
%
59.6
59.4
0.01
19
123
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
360
3143
1.17
2.03
4.5
4.2
%
21.5
21.5
0.01
174
1526
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
326
0.52
2.01
1.5
1.4
—
—
—
0
0
(4211845)
17
83
2.06
2.01
2.2
3.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
25
140
1.79
2.01
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
324
0.52
1.98
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
42
272
1.55
1.98
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
45
297
1.53
1.95
1.4
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
335
0.53
1.95
1.6
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
72
522
1.39
1.94
1.3
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
33
2.73
1.93
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
33
2.73
1.93
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
33
2.73
1.93
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
36
227
1.60
1.90
1.7
2.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
152
1231
1.25
1.88
1.3
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
45
300
1.51
1.88
1.2
1.4
u/ml
126.7
123.0
0.08
11
58
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
65
2.16
1.88
1.1
1.2
—
—
—
0
0
(44806071)
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
52
2.31
1.87
1.1
1.1
—
—
—
0
0
(4306422)
41
268
1.54
1.87
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
46
2.40
1.85
1.1
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
190
1.64
1.84
1.2
1.2
u/l
57.6
54.8
0.20
18
139
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
17
3.54
1.84
4.8
3.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
17
3.54
1.84
1.7
1.9
umol/l
41.7
47.1
—
6
17
(4281824)
12
249
0.48
1.82
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
53
2.27
1.80
1.1
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
35
2.58
1.80
1.3
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
23
3.05
1.80
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
80
599
1.35
1.79
2.5
2.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
70
513
1.38
1.79
2.6
2.4
g/l
0.1
0.0
0.57
62
477
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
66
480
1.39
1.77
2.6
2.4
g/l
0.0
0.0
0.00
58
446
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
305
1.48
1.75
1.6
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
95
1.90
1.75
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
286
2484
1.17
1.74
1.6
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
132
1.75
1.73
1.0
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
72
534
1.36
1.72
2.5
2.3
g/l
37.9
37.5
0.20
62
461
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
68
2.07
1.70
3.6
3.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
19
104
1.83
1.67
1.3
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
25
149
1.69
1.67
1.5
2.4
u/field
1.2
1.4
0.07
13
61
(3040151) Glucose [Moles/volume] in Capillary blood
29
180
1.62
1.66
40.8
5.2
mmol/l
7.8
7.3
0.41
24
154
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
268
1.50
1.66
1.5
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
47
326
1.45
1.65
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
56
2.15
1.61
1.8
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
28
175
1.61
1.57
2.2
2.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
77
587
1.32
1.56
2.6
2.5
g/l
0.8
1.1
0.31
65
513
(40759836) Histone Ab [Presence] in Serum by Immunoblot
23
137
1.69
1.55
1.5
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
23
137
1.69
1.55
1.5
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
23
137
1.69
1.55
1.5
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
41
281
1.47
1.55
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
323
1.43
1.53
1.1
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
15
3.34
1.52
1.4
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
64
477
1.35
1.52
2.7
2.4
g/l
0.0
0.0
0.00
58
446
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
70
529
1.33
1.52
3.4
3.5
mg/l
58.5
62.5
0.04
59
433
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
23
138
1.67
1.51
1.5
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
23
138
1.67
1.51
1.5
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
23
138
1.67
1.51
1.5
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
27
2.60
1.51
1.0
1.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
30
193
1.56
1.51
1.4
1.4
mosm/kgh2o
276.3
277.6
0.15
21
144
(3051611) Lipemic interference index of Serum or Plasma
30
194
1.55
1.48
3.7
3.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
53
720
0.73
1.48
1.6
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
167
0.48
1.47
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
5
16
3.13
1.44
1.2
1.3
pmol/l
5.5
14.9
—
5
16
(3051593) INR in Capillary blood by Coagulation assay
14
73
1.92
1.43
7.9
13.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
22
2.73
1.43
2.5
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
95
1.80
1.43
1.1
1.3
nmol/l
126.6
135.6
0.40
17
95
(3001019) Free T4 and TSH panel - Serum or Plasma
91
1140
0.79
1.42
1.7
1.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
42
297
1.42
1.37
1.3
1.4
nmol/l
0.5
0.4
0.30
32
224
(3037756) Immunofixation for Serum or Plasma
48
348
1.39
1.37
1.7
1.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
89
1.80
1.37
2.7
2.5
mmol/l
8.3
9.5
—
8
73
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
76
592
1.29
1.36
1.8
1.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
17
2.95
1.36
1.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
55
409
1.35
1.35
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
90
1.78
1.33
1.1
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
90
1.78
1.33
1.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
90
1.78
1.33
1.1
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
90
1.78
1.33
1.1
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
26
392
0.66
1.31
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
194
1676
1.17
1.30
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
26
391
0.66
1.30
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
26
391
0.66
1.30
1.5
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
67
517
1.30
1.29
3.2
3.5
ratio
1.2
1.6
—
8
46
(4094501)
63
482
1.32
1.29
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
26
390
0.66
1.29
1.5
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
23
145
1.59
1.29
1.6
1.5
%
20.6
33.6
1.14
15
85
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
69
1.89
1.28
1.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
69
1.89
1.28
1.1
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
42
302
1.40
1.27
1.1
1.2
u/ml
298.6
264.0
0.37
31
184
(3009542) Hematocrit [Volume Fraction] of Blood
1767
17242
1.10
1.26
20.0
14.5
%
39.5
39.5
0.07
1252
12642
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
36
2.23
1.24
1.3
1.5
—
—
—
0
0
(3036603) Volume of Urine
20
123
1.63
1.24
1.6
1.5
ml
1961.3
1895.6
—
6
19
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
395
3597
1.12
1.23
1.6
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
68
530
1.29
1.23
3.5
3.5
mg/l
42.2
66.6
0.93
58
432
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
71
558
1.28
1.21
2.1
2.1
%
95.7
91.1
1.12
63
518
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
280
1.40
1.20
1.2
1.1
iu/ml
3243.1
2087.7
—
10
61
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
47
349
1.35
1.19
2.7
2.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
26
2.31
1.18
2.0
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
231
1.43
1.17
1.6
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1645
16020
1.09
1.16
24.7
17.2
g/l
332.5
331.6
3.86
1632
15899
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
112
0.45
1.13
9.8
13.2
nmol/l
557.6
852.4
—
5
106
(3042111) Morphology [Interpretation] in Bone marrow Narrative
39
284
1.38
1.12
1.3
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
21
2.38
1.09
1.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
152
1.52
1.09
1.2
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
152
1.52
1.09
1.2
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
152
1.52
1.09
1.2
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
89
1.69
1.07
1.2
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
170
1483
1.16
1.05
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
50
384
1.31
1.04
3.6
3.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
90
1.67
1.04
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
34
463
0.73
1.03
1.8
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
187
1.45
1.03
1.4
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
98
1.64
1.03
2.1
2.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
11
60
1.84
1.02
2.4
2.5
%
117.1
159.7
1.03
11
55
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
27
188
1.44
1.01
2.6
4.9
u/ml
364.2
92.6
—
6
53
(3000034) Microalbumin [Mass/volume] in Urine
22
147
1.50
1.00
3.0
3.1
mg/l
9.8
34.6
1.35
16
107
(3029075) Extractable nuclear Ab panel - Serum
9
48
1.88
1.00
1.1
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
46
352
1.31
0.99
1.4
1.9
nmol/l
1.0
0.8
0.78
38
295
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
425
0.73
0.99
1.5
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
29
0.00
0.97
0.0
3.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
21
140
1.50
0.97
2.4
1.9
%
44.8
42.1
—
6
15
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
20
132
1.52
0.97
1.9
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
25
174
1.44
0.95
1.4
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
117
1.54
0.93
1.8
2.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
17
109
1.56
0.93
1.4
1.3
—
761.8
—
0
11
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
27
2.23
0.93
11.3
8.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
27
2.23
0.93
1.7
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
70
1.72
0.92
2.0
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
52
1.73
0.92
1.7
1.5
ug/l
9.3
9.0
—
9
52
(3027944) Amphetamines [Presence] in Urine
64
518
1.24
0.91
1.7
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
23
159
1.45
0.91
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
94
1.60
0.90
1.1
1.0
u/ml
0.1
1.0
—
6
33
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
88
738
1.20
0.90
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
60
484
1.25
0.89
1.8
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
64
521
1.23
0.88
1.7
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
31
229
1.36
0.86
1.1
1.1
u/ml
1.2
3.1
—
8
81
(4146454)
25
178
1.41
0.86
2.8
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
223
2013
1.12
0.86
1.8
1.8
%
1.4
1.4
0.05
188
1773
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
31
1.94
0.84
1.8
1.7
mmol/l
1.2
1.2
—
6
31
(3027008) Opiates [Presence] in Urine
64
524
1.23
0.84
1.7
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
55
443
1.25
0.83
2.4
3.0
mg/l
1.5
1.5
0.07
50
407
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
154
1.43
0.83
1.3
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
266
1.32
0.82
1.1
1.1
u/ml
1.0
3.4
—
9
128
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
46
1.74
0.82
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
64
526
1.22
0.82
1.7
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
45
355
1.27
0.81
4.3
3.6
%
57.3
57.6
0.06
45
355
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
81
1.61
0.81
2.2
2.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
44
347
1.27
0.80
1.9
2.8
umol/l
31.9
35.0
0.51
35
293
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
10
58
1.73
0.79
1.2
2.6
—
46866.3
—
0
10
(3035320) C reactive protein [Mass/volume] in Body fluid
20
139
1.44
0.79
4.4
2.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
33
1.82
0.79
1.8
1.7
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.5
—
1477781.9
—
0
18
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
26
0.00
0.78
0.0
3.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
536
5067
1.08
0.77
1.4
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
22
157
1.41
0.76
1.1
1.3
e6/l
33247.9
75604.4
0.44
13
111
(3042631) Mycobacterium sp identified in Specimen
30
226
1.33
0.76
3.2
2.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
16
107
1.50
0.76
1.4
1.3
—
81.8
—
0
11
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
244
1.32
0.75
1.1
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
17
243
0.70
0.74
1.7
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
83
709
1.18
0.73
1.5
1.6
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
25
2.00
0.72
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
21
288
0.73
0.72
2.0
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
39
1.80
0.72
1.6
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
68
1.62
0.71
2.4
1.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
26
1.93
0.70
2.0
2.1
—
—
—
0
0
(4268621)
25
186
1.35
0.70
2.7
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
169
1.36
0.69
3.8
2.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
40
319
1.26
0.69
1.1
1.1
u/ml
0.5
1.6
1.03
12
126
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
61
1.64
0.68
1.6
2.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
119
1.43
0.67
1.3
1.1
—
—
—
0
0
(44806420)
7
43
1.63
0.66
1.7
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
55
457
1.21
0.66
4.6
4.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
78
1.54
0.65
2.6
3.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
34
268
1.27
0.65
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
220
2021
1.10
0.65
1.8
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
120
1.42
0.64
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
51
423
1.21
0.63
1.7
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
49
1.63
0.62
1.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
8
49
1.63
0.62
8.9
6.7
mmol/l
25.0
25.2
—
8
44
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
379
1.22
0.61
1.5
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
37
298
1.25
0.61
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
88
1.48
0.60
1.2
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
59
500
1.18
0.60
1.1
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
187
1713
1.10
0.60
2.2
2.1
g/l
0.2
0.2
3.43
176
1597
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
105
1180
0.88
0.59
1.4
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
86
0.58
0.56
1.6
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
37
1.62
0.55
11.3
8.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
18
240
0.75
0.55
1.8
1.7
—
—
—
0
0
(4133840)
6
38
1.58
0.54
1.5
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
27
213
1.27
0.54
1.1
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
134
1.35
0.53
1.3
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
35
286
1.23
0.52
1.0
1.1
u/ml
1.0
2.9
1.87
14
132
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
64
1.41
0.51
4.2
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
658
6817
0.95
0.50
2.9
2.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
41
1.46
0.50
1.2
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
67
1.49
0.49
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
127
1.34
0.49
1.6
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
110
1.37
0.48
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
48
1.46
0.46
1.1
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
48
1.46
0.46
1.1
2.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
26
209
1.25
0.46
1.0
1.1
u/ml
0.7
3.7
—
5
80
(44806118)
25
200
1.25
0.46
1.8
1.5
—
—
—
0
0
(44790049)
25
200
1.25
0.46
1.8
1.5
—
—
—
0
0
(44790048)
25
200
1.25
0.46
1.8
1.5
—
—
—
0
0
(44790047)
25
200
1.25
0.46
1.8
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
13
94
1.39
0.46
1.5
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
160
1729
0.92
0.46
1.7
1.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
276
1.20
0.42
1.0
1.1
u/ml
1.5
1.5
0.01
13
110
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
58
1.38
0.41
2.0
1.9
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
33
1.52
0.41
1.2
1.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
417
1.15
0.40
1.7
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
64
568
1.13
0.40
3.0
3.1
u/ml
0.3
0.4
0.22
39
321
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
34
1.47
0.40
3.4
2.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
55
484
1.14
0.39
1.9
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
35
1.43
0.39
1.6
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
182
0.77
0.39
2.0
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
19
0.00
0.39
0.0
1.3
—
114.9
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
29
343
0.84
0.36
1.7
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
35
300
1.17
0.36
1.7
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
42
1.43
0.35
11.3
8.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
61
546
1.12
0.35
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
20
244
0.82
0.35
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
173
1.22
0.33
4.5
3.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
44
388
1.14
0.32
4.4
3.5
mg/l
17.7
25.9
1.61
33
252
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
155
1.23
0.32
1.1
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
47
1.28
0.32
1.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
128
1.25
0.32
3.3
6.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
131
1228
1.07
0.30
2.1
3.5
u/ml
33.4
59.0
1.49
123
1185
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
7
54
1.30
0.30
3.1
3.2
mg/l
9.4
7.5
—
7
48
(1002224) Polysomnography panel
85
783
1.09
0.30
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
77
706
1.09
0.30
2.1
1.7
mg/l
3.8
3.9
0.02
60
491
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
25
212
1.18
0.30
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
175
1.20
0.30
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
120
1.25
0.30
2.7
3.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
157
1.21
0.29
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
185
1.19
0.29
2.0
2.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
42
375
1.12
0.27
2.5
3.5
u/ml
63.9
1138.4
0.94
36
351
(3033705) Calcium.ionized [Moles/volume] in Venous blood
26
224
1.16
0.27
2.0
2.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
10
77
1.30
0.26
1.7
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
77
1.30
0.26
1.2
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
72
0.69
0.26
1.6
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
240
2308
1.04
0.25
3.3
3.0
ug/l
0.7
0.8
0.41
171
1526
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
142
1.20
0.24
1.4
1.5
umol/l
12.1
12.4
0.06
17
134
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
1.1
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
1.1
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
41
369
1.11
0.24
1.9
2.2
ug/min
153.4
78.7
0.42
20
227
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
236
1.15
0.24
1.5
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
84
0.71
0.24
1.3
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
369
0.89
0.23
1.9
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
92
0.76
0.22
1.0
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
92
0.76
0.22
1.0
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
153
1.18
0.22
1.9
1.7
%
10.4
11.0
0.35
18
153
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.8
—
25.4
—
0
10
(3013762) Body weight Measured
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
43
1.16
0.21
3.6
4.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
89
1.24
0.21
2.3
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
13
0.00
0.21
0.0
5.7
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.0
—
7.7
—
0
13
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.0
—
38.6
—
0
13
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.0
—
21.6
—
0
13
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
187
0.85
0.20
1.3
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
50
1.20
0.19
2.8
2.8
—
126.1
—
0
7
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
11
90
1.22
0.19
1.3
1.4
pmol/l
457.1
320.7
—
5
35
(3043410) Blood group antigens tested for on Red Blood Cells
6
52
1.15
0.19
1.8
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
54
501
1.08
0.19
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
27
242
1.12
0.18
1.9
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
34
310
1.10
0.17
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
148
1.15
0.17
1.2
1.5
g/l
0.9
1.0
0.59
17
148
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
148
1.15
0.17
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
311
1.09
0.16
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
92
1.20
0.16
1.2
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
8
73
1.10
0.15
57.1
25.9
ug/l
129.1
118.6
—
8
62
(3014271) Vancomycin [Susceptibility]
6
77
0.78
0.15
3.8
2.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
78
0.77
0.15
1.2
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
10
83
1.21
0.15
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
170
0.88
0.13
1.4
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
128
0.86
0.13
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
104
1.15
0.12
1.2
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
77
802
0.96
0.11
1.5
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
10
86
1.16
0.11
1.1
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
192
1.09
0.10
2.1
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
177
0.90
0.10
1.6
1.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
1.4
2.2
mg/l
7.4
9.3
—
5
37
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
113
0.88
0.08
1.5
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
88
1.14
0.08
1.1
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
66
1.06
0.08
2.0
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
244
1.07
0.08
1.3
1.3
mmol/l
7.6
7.4
0.13
20
178
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
67
1.04
0.08
1.3
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
166
1.08
0.07
4.2
3.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
98
1.12
0.07
1.5
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
16
174
0.92
0.07
1.8
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
304
1.05
0.07
1.8
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
94
0.85
0.06
1.0
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
188
1.06
0.05
1.5
1.3
e6/l
267198.7
104846.0
0.44
15
109
(40768441) Liver Pathology biopsy report
15
140
1.07
0.04
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
138
0.94
0.02
1.8
1.5
—
—
—
0
0
(4035726)
171
1723
0.99
0.02
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
195
1962
0.99
0.02
3.1
4.1
ug/l
20.3
22.3
0.05
152
1572
(3027456) Digoxin [Moles/volume] in Serum or Plasma
39
382
1.02
0.01
4.3
3.1
nmol/l
0.8
0.8
0.71
34
299
(1617658) Protocol used for examination of sentinel lymph nodes
19
197
0.96
0.01
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
67
664
1.01
0.00
3.1
3.5
u/ml
104.5
2317.4
0.82
60
559
(3004775) Volume in Urine collected for unspecified duration
12
115
1.04
0.00
2.3
2.0
ml
791.4
635.2
—
7
77
(3045142) Bone marrow Pathology biopsy report
20
198
1.01
0.00
1.1
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
318
1.01
0.00
1.1
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
10
97
1.03
0.00
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
97
1.03
0.00
1.5
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
50
1.00
0.00
1.6
1.5
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
70.2
—
0
5
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
4.6
—
15.0
—
0
5
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
8
0.00
0.00
0.0
9.9
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.3
—
3.9
—
0
8
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
14.1
—
0
7
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
64
0.94
0.00
1.7
1.3
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
8
0.00
0.00
0.0
5.1
—
380.9
—
0
8
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
10.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
8
84
0.95
0.00
2.8
6.6
—
60.4
—
0
22
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
55
0.91
0.00
1.2
1.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_TRINEU and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_TRINEU | 1.008 [0.9, 1.12] | 0.882 |
| Birth year | 0.995 [0.99, 1.0] | 0.284 |
During the follow-up period (1.1.1998 — 31.12.2019), 1123 out of 7824 females with G6_TRINEU died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_TRINEU | 1.14 [1.0, 1.29] | 0.044 |
| Birth year | 0.987 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 740 out of 3275 males with G6_TRINEU died.
Mortality risk
Mortality risk for people of age
years, who have G6_TRINEU.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.124% | 0.199% |
| 5 | 0.637% | 1.285% |
| 10 | 1.475% | 3.1% |
| 15 | 2.921% | 5.997% |
| 20 | 5.04% | 10.216% |
Relationships between endpoints
↥Index endpoint: G6_TRINEU – Trigeminal neuralgia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data